Professor John Cleland

  • Professor (Robertson Centre for Biostatistics)

Publications

List by: Type | Date

Jump to: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2005 | 2003 | 2002
Number of items: 246.

2017

Cleland, J. G.F. (2017) What do cardiology and homeopathy have in common? : A belief in aspirin? JACC: Heart Failure, 5(8), pp. 611-614. (doi:10.1016/j.jchf.2017.06.009) (PMID:28774397)

Gimpelewicz, C. et al. (2017) Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: a subgroup analysis from the RELAX-AHF trial. American Heart Journal, 190, pp. 113-122. (doi:10.1016/j.ahj.2017.05.012)

Halliday, B. P., Cleland, J. G.F. , Goldberger, J. J. and Prasad, S. K. (2017) Personalizing sudden death risk stratification in dilated cardiomyopathy: past, present and future. Circulation, 136(2), pp. 215-231. (doi:10.1161/CIRCULATIONAHA.116.027134) (PMID:28696268)

Damman, K. et al. (2017) Plasma neutrophil gelatinase-associated lipocalin and predicting clinically relevant worsening renal function in acute heart failure. International Journal of Molecular Sciences, 18(7), 1470. (doi:10.3390/ijms18071470) (PMID:28698481)

Shen, L. et al. (2017) Declining risk of sudden death in heart failure. New England Journal of Medicine, 377(1), pp. 41-51. (doi:10.1056/NEJMoa1609758) (PMID:28679089)

Cleland, J. G.F. , Pellicori, P., Clark, A. L. and Petrie, M. C. (2017) Time to take the failure out of heart failure: the importance of optimism. JACC: Heart Failure, 5(7), pp. 538-540. (doi:10.1016/j.jchf.2017.04.003) (PMID:28624485)

Pellicori, P., Clark, A. L., Kallvikbacka-Bennett, A., Zhang, J., Urbinati, A., Monzo, L., Dierckx, R., Anker, S. D. and Cleland, J. G.F. (2017) Non-invasive measurement of right atrial pressure by near-infrared spectroscopy: preliminary experience. A report from the SICA-HF study. European Journal of Heart Failure, 19(7), pp. 883-892. (doi:10.1002/ejhf.825) (PMID:28387033)

Liu, L. C.Y. et al. (2017) Identifying subpopulations with distinct response to treatment using plasma biomarkers in acute heart failure: results from the PROTECT trial. Cardiovascular Drugs and Therapy, (doi:10.1007/s10557-017-6726-1) (PMID:28656542) (Early Online Publication)

Sharma, A. et al. (2017) A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure. European Journal of Heart Failure, (doi:10.1002/ejhf.912) (PMID:28639369) (Early Online Publication)

Kotecha, D. et al. (2017) Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis. Journal of the American College of Cardiology, 69(24), pp. 2885-2896. (doi:10.1016/j.jacc.2017.04.001) (PMID:28467883)

McCoy, J. et al. (2017) Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients. Open Heart, (Accepted for Publication)

Ferreira, J. P. et al. (2017) Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. European Journal of Heart Failure, (doi:10.1002/ejhf.900) (PMID:28580625) (Early Online Publication)

Fröhlich, H. et al. (2017) Comparative effectiveness of enalapril, lisinopril and ramipril in the treatment of patients with chronic heart failure. A propensity score matched cohort study. European Heart Journal: Cardiovascular Pharmacotherapy, (doi:10.1093/ehjcvp/pvx013) (PMID:28475676) (Early Online Publication)

Jacobs, L. et al. (2017) Risk for incident heart failure: a subject-level meta-analysis from the Heart “OMics” in AGEing (HOMAGE) study. Journal of the American Heart Association, 6(5), e005231. (doi:10.1161/JAHA.116.005231) (PMID:28465299)

Zhang, J., Wong, K. Y.-K., Clark, A. L. and Cleland, J. G.F. (2017) Exploring the relation between changes in NT-proBNP and renal function in patients with suspected heart failure using structural equation modelling. International Journal of Cardiology, 233, pp. 67-72. (doi:10.1016/j.ijcard.2017.01.127) (PMID:28169056)

Fröhlich, H. et al. (2017) Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clinical Research in Cardiology, (Accepted for Publication)

McDiarmid, A. K., Pellicori, P., Cleland, J. G.F. and Plein, S. (2017) Taxonomy of segmental myocardial systolic dysfunction. European Heart Journal, 38(13), pp. 942-954. (doi:10.1093/eurheartj/ehw140) (PMID:27147609) (PMCID:PMC5381597)

Brown, D. A. et al. (2017) Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nature Reviews Cardiology, 14, pp. 238-250. (doi:10.1038/nrcardio.2016.203) (PMID:28004807)

Cleland, J. G.F. and Mueller, C. (2017) What can we learn from SOCRATES: more questions than answers? European Heart Journal, 38(15), pp. 1128-1131. (doi:10.1093/eurheartj/ehw561) (PMID:28204466)

Nymo, S. H. et al. (2017) Limited added value of circulating inflammatory biomarkers in chronic heart failure. JACC: Heart Failure, 5(4), pp. 256-264. (doi:10.1016/j.jchf.2017.01.008) (PMID:28359413)

Skobel, E. et al. (2017) Internet-based training of coronary artery patients: the Heart Cycle Trial. Heart and Vessels, 32(4), pp. 408-418. (doi:10.1007/s00380-016-0897-8) (PMID:27730298)

Halliday, B. P. et al. (2017) Association between mid-wall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation, (doi:10.1161/CIRCULATIONAHA.116.026910) (PMID:28351901) (Early Online Publication)

Salvi, D. et al. (2017) An m-health system for education and motivation in cardiac rehabilitation: the experience of heartcycle guided exercise. Journal of Telemedicine and Telecare, (doi:10.1177/1357633X17697501) (PMID:28350282) (Early Online Publication)

Liu, L. C.Y. et al. (2017) Plasma biomarkers to determine individual response to rolofylline in acute heart failure: results from the PROTECT trial. Cardiovascular Drugs and Therapy, (Accepted for Publication)

Rao, M. P. et al. (2017) Sudden cardiac death in patients with ischemic heart failure undergoing coronary artery bypass grafting results from the STICH randomized clinical trial (Surgical Treatment for Ischemic Heart Failure). Circulation, 135, pp. 1136-1144. (doi:10.1161/CIRCULATIONAHA.116.026075) (PMID:28154006)

Dovancescu, S., Pellicori, P., Mabote, T., Torabi, A., Clark, A. L. and Cleland, J. G.F. (2017) The effects of short-term omission of daily medication on the pathophysiology of heart failure. European Journal of Heart Failure, (doi:10.1002/ejhf.748) (PMID:28295907)

Linde, C., Abraham, W. T., Gold, M. R., Daubert, C., Tang, A. S.L., Young, J. B., Sherfesee, L., Hudnall, H., Fagan, D. H. and Cleland, J. G. (2017) Predictors of short-term clinical response to cardiac resynchronization therapy. European Journal of Heart Failure, (doi:10.1002/ejhf.795) (PMID:28295869) (Early Online Publication)

Ouwerkerk, W. et al. (2017) Determinants and clinical outcome of uptitration of ACE-inhibitor and beta-blocker in patients with heart failure: a prospective European study. European Heart Journal, (doi:10.1093/eurheartj/ehx026) (PMID:28329163) (Early Online Publication)

Cleland, J. G.F. et al. (2017) Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). European Journal of Heart Failure, (doi:10.1002/ejhf.786) (PMID:28296139) (Early Online Publication)

Fröhlich, H. et al. (2017) Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure. International Journal of Cardiology, (doi:10.1016/j.ijcard.2017.03.028) (PMID:28342630) (In Press)

Filippatos, G. S. et al. (2017) Independent academic data monitoring committees for clinical trials in cardiovascular and cardiometabolic diseases. European Journal of Heart Failure, (doi:10.1002/ejhf.761) (PMID:28271595) (Early Online Publication)

Demissei, B. G. et al. (2017) Plasma biomarkers to predict or rule out early post-discharge events in patients discharged after an acute heart failure hospital admission. European Journal of Heart Failure, (doi:10.1002/ejhf.766) (PMID:28251755) (Early Online Publication)

Voors, A. A. et al. (2017) Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. European Journal of Heart Failure, (doi:10.1002/ejhf.785) (PMID:28247565) (Early Online Publication)

Dierckx, R., Inglis, S. C., Clark, R. A., Prieto-Merino, D. and Cleland, J. G.F. (2017) Telemedicine in heart failure: new insights from the Cochrane meta-analyses. European Journal of Heart Failure, 19(3), pp. 304-306. (doi:10.1002/ejhf.759) (PMID:28251777)

Masters, J., Morton, G., Anton, I., Szymanski, J., Greenwood, E., Grogono, J., Flett, A. S., Cleland, J. G.F. and Cowburn, P. J. (2017) Specialist intervention is associated with improved patient outcomes in patients with decompensated heart failure: evaluation of the impact of a multidisciplinary inpatient heart failure team. Open Heart, 4(1), e000547. (doi:10.1136/openhrt-2016-000547)

Matsue, Y. et al. (2017) Clinical correlates and prognostic value of proenkephalin in acute and chronic heart failure. Journal of Cardiac Failure, 23(3), pp. 231-239. (doi:10.1016/j.cardfail.2016.09.007) (PMID:27663098)

Matsue, Y. et al. (2017) Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure. Heart, 103(6), pp. 407-413. (doi:10.1136/heartjnl-2016-310112) (PMID:27658757)

Pellicori, P., Urbinati, A., Shah, P., MacNamara, A., Kazmi, S., Dierckx, R., Zhang, J., Cleland, J. G.F. and Clark, A. L. (2017) What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan? European Journal of Heart Failure, (doi:10.1002/ejhf.788) (PMID:28244205) (Early Online Publication)

Zakeri, R. et al. (2017) The burden of proof: the current state of atrial fibrillation prevention and treatment trials. Heart Rhythm, (doi:10.1016/j.hrthm.2017.01.032) (PMID:28161513) (In Press)

Emdin, C. A. et al. (2017) Referral for specialist follow-up and its association with post-discharge mortality among patients with systolic heart failure (from the National Heart Failure Audit for England and Wales). American Journal of Cardiology, 119(3), pp. 440-444. (doi:10.1016/j.amjcard.2016.10.021) (PMID:27884420)

Gastelurrutia, P., Lupón, J., Domingo, M., Stut, W., Dovancescu, S., Cleland, J. , Frankenstein, L. and Bayes-Genis, A. (2017) Potential role for clinical calibration to increase engagement with and application of home telemonitoring: a report from the HeartCycle programme. ESC Heart Failure, 4(1), pp. 66-70. (doi:10.1002/ehf2.12104) (PMID:28217314) (PMCID:PMC5292630)

Zhang, J., Dierckx, R., Mohee, K., Clark, A. L. and Cleland, J. G.F. (2017) Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis. ESC Heart Failure, 4(1), pp. 40-45. (doi:10.1002/ehf2.12112) (PMID:28217311) (PMCID:PMC5292634)

Streng, K. W. et al. (2017) Associations of body mass index with laboratory and biomarkers in patients with acute heart failure. Circulation: Heart Failure, 10(1), e003350. (doi:10.1161/CIRCHEARTFAILURE.116.003350) (PMID:28069685)

Tromp, J. et al. (2017) Serum potassium levels and outcome in acute heart failure (data from the PROTECT and COACH trials). American Journal of Cardiology, 119(2), pp. 290-296. (doi:10.1016/j.amjcard.2016.09.038) (PMID:27823598)

Arain, F., Gullestad, L., Nymo, S., Kjekshus, J., Cleland, J. G.F. , Michelsen, A., McMurray, J. J.V. , Wikstrand, J., Aukrust, P. and Ueland, T. (2017) Low YKL-40 in Chronic Heart Failure may predict beneficial effects of statins: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Biomarkers, 22, pp. 261-267. (doi:10.1080/1354750X.2016.1204003) (PMID:27325138)

Ritchie, J. et al. (2017) Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial. Nephrology Dialysis Transplantation, 32(6), pp. 1006-1013. (doi:10.1093/ndt/gfw107)

2016

Torabi, A. et al. (2016) Influence of case definition on incidence and outcome of acute coronary syndromes. Open Heart, 3(2), e000487. (doi:10.1136/openhrt-2016-000487)

Koudstaal, S. et al. (2016) Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. European Journal of Heart Failure, (doi:10.1002/ejhf.709) (PMID:28008698) (Early Online Publication)

Cleland, J. G.F. (2016) Does aspirin detract from the benefits of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction? Probably! European Journal of Heart Failure, (doi:10.1002/ejhf.697) (PMID:27943554) (Early Online Publication)

Teerlink, J. R. et al. (2016) Chronic oral study of myosin activation to increase contractility in heart failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial. Lancet, 388(10062), pp. 2895-2903. (doi:10.1016/S0140-6736(16)32049-9)

Vegter, E. L. et al. (2016) Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure. International Journal of Cardiology, 224, pp. 231-239. (doi:10.1016/j.ijcard.2016.09.010) (PMID:27661412)

Pellicori, P., Cleland, J. G.F. , Zhang, J., Kallvikbacka-Bennett, A., Urbinati, A., Shah, P., Kazmi, S. and Clark, A. L. (2016) Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure. Cardiovascular Drugs and Therapy, 30(6), pp. 599-609. (doi:10.1007/s10557-016-6697-7) (PMID:27819111)

Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D. and Cleland, J. G.F. (2016) Structured telephone support or non-invasive telemonitoring for patients with heart failure. Heart, 103(4), pp. 255-257. (doi:10.1136/heartjnl-2015-309191) (PMID:27864319)

Demissei, B. G. et al. (2016) Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure — Post-hoc analysis of the PROTECT trial. International Journal of Cardiology, 223, pp. 967-975. (doi:10.1016/j.ijcard.2016.08.271) (PMID:27589047)

Ferreira, J. P. et al. (2016) Renal function estimation and Cockroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: the Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives. BMC Medicine, 14, 181. (doi:10.1186/s12916-016-0731-2) (PMID:27829460) (PMCID:PMC5103492)

Bekfani, T. et al. (2016) Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life. International Journal of Cardiology, 222, pp. 41-46. (doi:10.1016/j.ijcard.2016.07.135) (PMID:27454614)

Tromp, J. et al. (2016) Acute heart failure in the young: clinical characteristics and biomarker profiles. International Journal of Cardiology, 221, pp. 1067-1072. (doi:10.1016/j.ijcard.2016.06.339) (PMID:27448534)

Sokoreli, I. et al. (2016) Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failure. International Journal of Cardiology, 220, pp. 202-207. (doi:10.1016/j.ijcard.2016.06.068) (PMID:27389442)

Cotter, G. et al. (2016) Predictors and associations with outcomes of length of hospital stay in patients with acute heart failure: results from VERITAS. Journal of Cardiac Failure, 22(10), pp. 815-822. (doi:10.1016/j.cardfail.2015.12.017) (PMID:26721775)

ter Maaten, J. M. et al. (2016) Hypochloremia, diuretic resistance, and outcome in patients with acute heart failure. Circulation: Heart Failure, 9(8), e003109. (doi:10.1161/CIRCHEARTFAILURE.116.003109) (PMID:27507112)

Bhattacharyya, S., Mittal, T., Abayalingam, M., Kabir, T., Dalby, M., Cleland, J. G.F. , Baltabaeva, A. and Rahman Haley, S. (2016) Classification of aortic stenosis by flow and gradient patterns provides insights into the pathophysiology of disease. Angiology, 67(7), pp. 664-669. (doi:10.1177/0003319715611804) (PMID:26475710)

Cleland, J. G.F. , Zhang, J., Pellicori, P., Dicken, B., Dierckx, R., Shoaib, A., Wong, K., Rigby, A., Goode, K. and Clark, A. L. (2016) Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiology, 1(5), pp. 539-547. (doi:10.1001/jamacardio.2016.1161) (PMID:27439011)

Davison, B. A. et al. (2016) Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. European Journal of Heart Failure, 18(8), pp. 1041-1050. (doi:10.1002/ejhf.540) (PMID:27114058)

Fröhlich, H. et al. (2016) Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease. American Heart Journal, 178, pp. 28-36. (doi:10.1016/j.ahj.2016.03.024) (PMID:27502849)

Ponikowski, P. et al. (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Journal of Heart Failure, 18(8), pp. 891-975. (doi:10.1002/ejhf.592) (PMID:27207191)

Biegus, J. et al. (2016) Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. European Journal of Heart Failure, 18(7), pp. 830-839. (doi:10.1002/ejhf.532) (PMID:27170455)

Feldman, T. et al. (2016) Transcatheter interatrial shunt device for the treatment of heart failure: rationale and design of the randomized trial to REDUCE elevated left atrial pressure in heart failure (REDUCE LAP-HF I). Circulation: Heart Failure, 9(7), e003025. (doi:10.1161/CIRCHEARTFAILURE.116.003025) (PMID:27330010)

Emmens, J. E. et al. (2016) Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome. European Journal of Heart Failure, 18(6), pp. 641-649. (doi:10.1002/ejhf.426) (PMID:26511274)

Voors, A. A. et al. (2016) A systems BIOlogy Study to TAilored treatment in chronic heart failure: rationale, design, and baseline characteristics of BIOSTAT-CHF. European Journal of Heart Failure, 18(6), pp. 716-726. (doi:10.1002/ejhf.531) (PMID:27126231)

ter Maaten, J. M. et al. (2016) Combining diuretic response and hemoconcentration to predict rehospitalization after admission for acute heart failure. Circulation: Heart Failure, 9(6), e002845. (doi:10.1161/CIRCHEARTFAILURE.115.002845) (PMID:27266853)

Pellicori, P., Goode, K. M., Nicholls, R., Ahmed, D., Clark, A. L. and Cleland, J. G.F. (2016) Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurements. International Journal of Cardiology, 210, pp. 149-155. (doi:10.1016/j.ijcard.2016.02.081) (PMID:26946041)

Gheorghiade, M. et al. (2016) Developing new treatments for heart failure: focus on the heart. Circulation: Heart Failure, 9(5), e002727. (doi:10.1161/CIRCHEARTFAILURE.115.002727) (PMID:27166246)

Shoaib, A. et al. (2016) Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1. European Journal of Heart Failure, 18(5), pp. 556-563. (doi:10.1002/ejhf.505) (PMID:26991150)

Kotecha, D. et al. (2016) Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. BMJ, 353, i1855. (doi:10.1136/bmj.i1855) (PMID:27098105) (PMCID:PMC4849174)

Ovchinnikova, E. S. et al. (2016) Signature of circulating microRNAs in patients with acute heart failure. European Journal of Heart Failure, 18(4), pp. 414-423. (doi:10.1002/ejhf.332) (PMID:26345695)

Teerlink, J. R. et al. (2016) Acute treatment with omecamtiv mecarbil to increase contractility in acute heart failure. Journal of the American College of Cardiology, 67(12), pp. 1444-1455. (doi:10.1016/j.jacc.2016.01.031) (PMID:27012405)

Hasenfuß, G. et al. (2016) A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet, 387(10025), pp. 1298-1304. (doi:10.1016/S0140-6736(16)00704-2) (PMID:27025436)

Damman, K., Kjekshus, J., Wikstrand, J., Cleland, J. G.F. , Komajda, M., Wedel, H., Waagstein, F. and McMurray, J. J.V. (2016) Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, 18(3), pp. 328-336. (doi:10.1002/ejhf.462) (PMID:26693947)

Demissei, B. G. et al. (2016) Optimizing clinical use of biomarkers in high-risk acute heart failure patients. European Journal of Heart Failure, 18(3), pp. 269-280. (doi:10.1002/ejhf.443) (PMID:26634889)

Cuba Gyllensten, I., Bonomi, A. G., Goode, K. M., Reiter, H., Habetha, J., Amft, O. and Cleland, J. G.F. (2016) Early indication of decompensated heart failure in patients on home-telemonitoring: a comparison of prediction algorithms based on daily weight and noninvasive transthoracic bio-impedance. JMIR Medical Informatics, 4(1), e3. (doi:10.2196/medinform.4842) (PMID:26892844) (PMCID:PMC4777885)

Demissei, B. G. et al. (2016) Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients. International Journal of Cardiology, 204, pp. 164-171. (doi:10.1016/j.ijcard.2015.11.141) (PMID:26666342)

Bhandari, S., Ives, N., Brettell, E. A., Valente, M., Cockwell, P., Topham, P. S., Cleland, J. G.F. , Khwaja, A. and El Nahas, M. (2016) Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial. Nephrology Dialysis Transplantation, 31(2), pp. 255-261. (doi:10.1093/ndt/gfv346) (PMID:26429974) (PMCID:PMC4725389)

ter Maaten, J. M. et al. (2016) A combined clinical and biomarker approach to predict diuretic response in acute heart failure. Clinical Research in Cardiology, 105(2), pp. 145-153. (doi:10.1007/s00392-015-0896-2) (PMID:26280875) (PMCID:PMC4735256)

Bruno, N. et al. (2016) MicroRNAs relate to early worsening of renal function in patients with acute heart failure. International Journal of Cardiology, 203, pp. 564-569. (doi:10.1016/j.ijcard.2015.10.217) (PMID:26569364)

Zhang, J., Hobkirk, J., Carroll, S., Pellicori, P., Clark, A. L. and Cleland, J. G.F. (2016) Exploring quality of life in patients with and without heart failure. International Journal of Cardiology, 202, pp. 676-684. (doi:10.1016/j.ijcard.2015.09.076) (PMID:26453816)

Cowie, M. R., Bax, J., Bruining, N., Cleland, J. G.F. , Koehler, F., Malik, M., Pinto, F., van der Velde, E. and Vardas, P. (2016) e-Health: a position statement of the European Society of Cardiology. European Heart Journal, 37(1), pp. 63-66. (doi:10.1093/eurheartj/ehv416) (PMID:26303835)

Emdin, C. A. et al. (2016) Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales. Heart, 103(1), pp. 55-62. (doi:10.1136/heartjnl-2016-309706) (PMID:27530132)

Ponikowski, P. et al. (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 37(27), pp. 2129-2200. (doi:10.1093/eurheartj/ehw128) (PMID:27206819)

2015

Cleland, J. G.F. and Mareev, Y. (2015) CRT for heart failure and ESRD: more trials or more thought needed? Journal of the American College of Cardiology, 66(23), pp. 2630-2632. (doi:10.1016/j.jacc.2015.10.022) (PMID:26670063)

Jolicœur, E. M. et al. (2015) Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction. Journal of the American College of Cardiology, 66(19), pp. 2092-2100. (doi:10.1016/j.jacc.2015.08.882) (PMID:26541919)

Pellicori, P., Joseph, A. C., Zhang, J., Lukaschuk, E., Sherwi, N., Bourantas, C. V., Loh, H., Clark, A. L. and Cleland, J. G.F. (2015) The relationship of QRS morphology with cardiac structure and function in patients with heart failure. Clinical Research in Cardiology, 104(11), pp. 935-945. (doi:10.1007/s00392-015-0861-0) (PMID:25903113)

Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D. and Cleland, J. G.F. (2015) Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database of Systematic Reviews, 2015(10), CD007228. (doi:10.1002/14651858.CD007228.pub3) (PMID:26517969)

Farag, M., Mabote, T., Shoaib, A., Zhang, J., Nabhan, A. F., Clark, A. L. and Cleland, J. G. (2015) Hydralazine and nitrates alone or combined for the management of chronic heart failure: a systematic review. International Journal of Cardiology, 196, pp. 61-69. (doi:10.1016/j.ijcard.2015.05.160) (PMID:26073215)

Mareev, Y. and Cleland, J. G.F. (2015) Should β-blockers be used in patients with heart failure and atrial fibrillation? Clinical Therapeutics, 37(10), pp. 2215-2224. (doi:10.1016/j.clinthera.2015.08.017) (PMID:26391145)

Butcher, C., Mareev, Y., Markides, V., Mason, M., Wong, T. and Cleland, J.G.F. (2015) Cardiac resynchronization therapy update: evolving indications, expanding benefit? Current Cardiology Reports, 17(10), 90. (doi:10.1007/s11886-015-0641-5) (PMID:26298308)

Frankenstein, L., Fröhlich, H. and Cleland, J. G.F. (2015) Multidisciplinary approach for patients hospitalized with heart failure. Revista Española de Cardiología (English Edition), 68(10), pp. 885-891. (doi:10.1016/j.rec.2015.05.008) (PMID:26409892)

Shadman, R. et al. (2015) A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model. Heart Rhythm, 12(10), pp. 2069-2077. (doi:10.1016/j.hrthm.2015.06.039) (PMID:26142301)

Cleland, J. G.F. and Freemantle, N. (2015) QRS morphology as a predictor of the response to cardiac resynchronisation therapy: fact or fashion? Heart, 101(18), pp. 1441-1443. (doi:10.1136/heartjnl-2015-307553) (PMID:26187602)

Damy, T. et al. (2015) Development of a human model for the study of effects of hypoxia, exercise, and sildenafil on cardiac and vascular function in chronic heart failure. Journal of Cardiovascular Pharmacology, 66(3), pp. 229-238. (doi:10.1097/FJC.0000000000000262) (PMID:25874853)

Dierckx, R., Cleland, J. G.F. , Pellicori, P., Zhang, J., Goode, K., Putzu, P., Boyalla, V. and Clark, A. L. (2015) If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment? Journal of Telemedicine and Telecare, 21(6), pp. 331-339. (doi:10.1177/1357633X15574947) (PMID:25766855)

Stut, W., Deighan, C., Cleland, J. G. and Jaarsma, T. (2015) Adherence to self-care in patients with heart failure in the HeartCycle study. Patient Preference and Adherence, 9, pp. 1195-1206. (doi:10.2147/PPA.S88482) (PMID:26316725) (PMCID:PMC4548736)

Askevold, E. T., Gullestad, L., Nymo, S., Kjekshus, J., Yndestad, A., Latini, R., Cleland, J. G.F. , McMurray, J. J.V. , Aukrust, P. and Ueland, T. (2015) Secreted frizzled related protein 3 in chronic heart failure: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA). PLoS ONE, 10(8), e0133970. (doi:10.1371/journal.pone.0133970) (PMID:26288364) (PMCID:PMC4545831)

Cleland, J. G.F. , Mareev, Y. and Linde, C. (2015) Reflections on EchoCRT: sound guidance on QRS duration and morphology for CRT? European Heart Journal, 36(30), pp. 1948-1951. (doi:10.1093/eurheartj/ehv264) (PMID:26180135)

Raphael, C. E., Finegold, J. A., Barron, A. J., Whinnett, Z. I., Mayet, J., Linde, C., Cleland, J. G.F. , Levy, W. C. and Francis, D. P. (2015) The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most? European Heart Journal, 36(26), pp. 1676-1688. (doi:10.1093/eurheartj/ehv102) (PMID:25908776)

Ferrari, R., Böhm, M., Cleland, J. G.F. , Paulus, W. J.S., Pieske, B., Rapezzi, C. and Tavazzi, L. (2015) Heart failure with preserved ejection fraction: uncertainties and dilemmas. European Journal of Heart Failure, 17(7), pp. 665-671. (doi:10.1002/ejhf.304) (PMID:26079097)

Mentz, R. J. et al. (2015) Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. European Journal of Heart Failure, 17(7), pp. 697-706. (doi:10.1002/ejhf.308) (PMID:26083764)

Pellicori, P., Kallvikbacka-Bennett, A., Dierckx, R., Zhang, J., Putzu, P., Cuthbert, J., Boyalla, V., Shoaib, A., Clark, A. L. and Cleland, J. G.F. (2015) Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure. Heart, 101(14), pp. 1149-1158. (doi:10.1136/heartjnl-2015-307558) (PMID:26006717)

Zannad, F., Greenberg, B., Cleland, J. G.F. , Gheorghiade, M., van Veldhuisen, D. J., Mehra, M. R., Anker, S. D., Byra, W. M., Fu, M. and Mills, R. M. (2015) Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial. European Journal of Heart Failure, 17(7), pp. 735-742. (doi:10.1002/ejhf.266) (PMID:25919061) (PMCID:PMC5029775)

Inglis, S. C., Conway, A., Cleland, J. G.F. and Clark, R. A. (2015) Is age a factor in the success or failure of remote monitoring in heart failure? Telemonitoring and structured telephone support in elderly heart failure patients. European Journal of Cardiovascular Nursing, 14(3), pp. 248-255. (doi:10.1177/1474515114530611) (PMID:24681423)

Kristensen, S. L., Jhund, P. S. , Køber, L., McKelvie, R. S., Zile, M. R., Anand, I. S., Komajda, M., Cleland, J. G.F. , Carson, P. E. and McMurray, J. J.V. (2015) Relative importance of history of heart failure hospitalization and N-terminal pro–B-type natriuretic peptide level as predictors of outcomes in patients with heart failure and preserved ejection fraction. JACC: Heart Failure, 3(6), pp. 478-486. (doi:10.1016/j.jchf.2015.01.014) (PMID:26046842)

Costanzo, P., Cleland, J. G.F. , Pellicori, P., Clark, A. L., Hepburn, D., Kilpatrick, E. S., Perrone-Filardi, P., Zhang, J. and Atkin, S. L. (2015) The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Annals of Internal Medicine, 162(9), pp. 610-618. (doi:10.7326/M14-1551) (PMID:25938991)

Davison, B. A. et al. (2015) Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies. JACC: Heart Failure, 3(5), pp. 395-403. (doi:10.1016/j.jchf.2015.01.007) (PMID:25951761)

Filippatos, G. et al. (2015) International REgistry to assess medical practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry. European Journal of Heart Failure, 17(5), pp. 527-533. (doi:10.1002/ejhf.262) (PMID:25754836) (PMCID:PMC5024037)

Cleland, J. G.F. and Butcher, C. (2015) When is it appropriate to withdraw cardiac resynchronization therapy? Guesses and evidence. JACC: Heart Failure, 3(4), pp. 337-339. (doi:10.1016/j.jchf.2015.01.003) (PMID:25770401)

Pellicori, P., Zhang, J., Lukaschuk, E., Joseph, A.C., Bourantas, C.V., Loh, H., Bragadeesh, T., Clark, A.L. and Cleland, J.G.F. (2015) Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value. European Heart Journal, 36(12), pp. 733-742. (doi:10.1093/eurheartj/ehu405) (PMID:25336215)

Jankowska, E. A. et al. (2015) Bone marrow iron depletion is common in patients with coronary artery disease. International Journal of Cardiology, 182, pp. 517-522. (doi:10.1016/j.ijcard.2014.10.006) (PMID:25661858)

Dierckx, R., Cleland, J. G.F. , Parsons, S., Putzu, P., Pellicori, P., Dicken, B., Boyalla, V. and Clark, A. L. (2015) Prescribing patterns to optimize heart rate. JACC: Heart Failure, 3(3), pp. 224-230. (doi:10.1016/j.jchf.2014.11.003) (PMID:25650369)

Khand, A. U., Chew, P. G., Douglas, H., Jones, J., Jan, A. and Cleland, J.G.F. (2015) The effect of carvedilol on b-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation. Cardiology, 130(3), pp. 153-158. (doi:10.1159/000368746) (PMID:25660493)

Metra, M. et al. (2015) Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study. Journal of Cardiac Failure, 21(3), pp. 179-88. (doi:10.1016/j.cardfail.2014.12.012) (PMID:25573829)

Pellicori, P. and Cleland, J. G.F. (2015) Update on management of heart failure with preserved ejection fraction. Current Opinion in Cardiology, 30(2), pp. 173-178. (doi:10.1097/HCO.0000000000000152) (PMID:25603033)

Kristensen, S. L. et al. (2015) Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. European Journal of Heart Failure, 17(2), pp. 169-176. (doi:10.1002/ejhf.211) (PMID:25756844)

Dickstein, K. et al. (2015) European cardiac resynchronization therapy survey II: rationale and design. Europace, 17(1), pp. 137-141. (doi:10.1093/europace/euu312) (PMID:25414481)

Dierckx, R., Pellicori, P., Cleland, J.G.F. and Clark, A.L. (2015) Telemonitoring in heart failure: Big Brother watching over you. Heart Failure Reviews, 20(1), pp. 107-116. (doi:10.1007/s10741-014-9449-4) (PMID:24972644)

Metra, M. et al. (2015) Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial. European Journal of Heart Failure, 17(1), pp. 109-118. (doi:10.1002/ejhf.207) (PMID:25431336)

2014

Badar, A. A. et al. (2014) Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). European Heart Journal, 35(48), pp. 3426-3433. (doi:10.1093/eurheartj/ehu342)

Kotecha, D. et al. (2014) Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet, 384(9961), pp. 2235-2243. (doi:10.1016/S0140-6736(14)61373-8) (PMID:25193873)

Stut, W., Deighan, C., Armitage, W., Clark, M., Cleland, J. G. and Jaarsma, T. (2014) Design and usage of the HeartCycle education and coaching program for patients with heart failure. JMIR Research Protocols, 3(4), e72. (doi:10.2196/resprot.3411) (PMID:25499976) (PMCID:PMC4275507)

Cotter, G. et al. (2014) Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study. European Journal of Heart Failure, 16(12), pp. 1362-1371. (doi:10.1002/ejhf.186) (PMID:25371147)

Pellicori, P. and Cleland, J. G.F. (2014) Heart failure with preserved ejection fraction. Clinical Medicine, 14(S6), s22-s28. (doi:10.7861/clinmedicine.14-6-s22) (PMID:25468914)

Shoaib, A. et al. (2014) Breathlessness at rest is not the dominant presentation of patients admitted with heart failure. European Journal of Heart Failure, 16(12), pp. 1283-1291. (doi:10.1002/ejhf.153) (PMID:25452165)

Ahmad, T. et al. (2014) Charting a roadmap for heart failure biomarker studies. JACC: Heart Failure, 2(5), pp. 477-488. (doi:10.1016/j.jchf.2014.02.005) (PMID:24929535) (PMCID:PMC4194170)

Cleland, J. G.F. , Hutchinson, K., Pellicori, P. and Clark, A. (2014) Lipid-modifying treatments for heart failure: is their use justified? Heart Failure Clinics, 10(4), pp. 621-634. (doi:10.1016/j.hfc.2014.07.006) (PMID:25217437)

Parsons, S., Clark, A. L. and Cleland, J. G.F. (2014) The remarkable effect of ivabradine in two adolescents with dilated cardiomyopathy. Clinical Research in Cardiology, 103(10), pp. 847-849. (doi:10.1007/s00392-014-0731-1) (PMID:24920068)

Jankowska, E. A. et al. (2014) Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. European Heart Journal, 35(36), pp. 2468-2476. (doi:10.1093/eurheartj/ehu235) (PMID:24927731)

Dicken, B. and Cleland, J. G.F. (2014) Is the way to a man’s heart through his stomach? Intestinal blood flow, gut permeability, and heart failure. Journal of the American College of Cardiology, 64(11), pp. 1103-1105. (doi:10.1016/j.jacc.2014.06.1180)

Hutchinson, K., Pellicori, P., Dierckx, R., Cleland, J. G.F. and Clark, A. L. (2014) Remote telemonitoring for patients with heart failure: might monitoring pulmonary artery pressure become routine? Expert Review of Cardiovascular Therapy, 12(8), pp. 1025-1033. (doi:10.1586/14779072.2014.935340) (PMID:24984847)

Mabote, T., Wong, K. and Cleland, J. G.F. (2014) The utility of novel non-invasive technologies for remote hemodynamic monitoring in chronic heart failure. Expert Review of Cardiovascular Therapy, 12(8), pp. 923-928. (doi:10.1586/14779072.2014.935339) (PMID:25026973)

Stewart, R. A.H. et al. (2014) Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). JACC: Heart Failure, 2(4), pp. 335-343. (doi:10.1016/j.jchf.2014.02.009) (PMID:25023813) (PMCID:PMC4127151)

Cleland, J. G.F. , Pellicori, P. and Dierckx, R. (2014) Clinical trials in patients with heart failure and preserved left ventricular ejection fraction. Heart Failure Clinics, 10(3), pp. 511-523. (doi:10.1016/j.hfc.2014.04.011) (PMID:24975913)

Cullington, D., Goode, K. M., Zhang, J., Cleland, J. G.F. and Clark, A. L. (2014) Is heart rate important for patients with heart failure in atrial fibrillation? JACC: Heart Failure, 2(3), pp. 213-220. (doi:10.1016/j.jchf.2014.01.005) (PMID:24952686)

Goode, K. M., Nicholls, R., Pellicori, P., Clark, A. L. and Cleland, J. G.F. (2014) The in vitro stability of novel cardiovascular and sepsis biomarkers at ambient temperature. Clinical Chemistry and Laboratory Medicine, 52(6), pp. 911-918. (doi:10.1515/cclm-2013-0767) (PMID:24406281)

Ingle, L., Cleland, J.G. and Clark, A.L. (2014) The relation between repeated 6-minute walk test performance and outcome in patients with chronic heart failure. Annals of Physical and Rehabilitation Medicine, 57(4), pp. 244-253. (doi:10.1016/j.rehab.2014.03.004) (PMID:24835160)

Mentz, R. J. et al. (2014) International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial. European Journal of Heart Failure, 16(6), pp. 614-624. (doi:10.1002/ejhf.92) (PMID:24771609)

Rogers, J. K. et al. (2014) Effect of rosuvastatin on repeat heart failure hospitalizations: The CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC: Heart Failure, 2(3), pp. 289-297. (doi:10.1016/j.jchf.2013.12.007)

Valente, M.A.E. et al. (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. European Heart Journal, 35(19), pp. 1284-1293. (doi:10.1093/eurheartj/ehu065) (PMID:24585267)

Ingle, L., Rigby, A. S., Sloan, R., Carroll, S., Goode, K. M., Cleland, J. G. and Clark, A. L. (2014) Development of a composite model derived from cardiopulmonary exercise tests to predict mortality risk in patients with mild-to-moderate heart failure. Heart, 100(10), pp. 781-786. (doi:10.1136/heartjnl-2013-304614) (PMID:24567314)

Mentz, R. J. et al. (2014) Decongestion in acute heart failure. European Journal of Heart Failure, 16(5), pp. 471-482. (doi:10.1002/ejhf.74) (PMID:24599738) (PMCID:PMC4659502)

Cleland, J. G.F. and Parsons, S. (2014) Aspirin for heart failure: theory- or evidence-based? Circulation: Heart Failure, 7(2), pp. 237-238. (doi:10.1161/CIRCHEARTFAILURE.114.001155) (PMID:24643886)

Poolsawad, N., Moore, L., Kambhampati, C. and Cleland, J. G.F. (2014) Issues in the mining of heart failure datasets. International Journal of Automation and Computing, 11(2), pp. 162-179. (doi:10.1007/s11633-014-0778-5)

Perez-Moreno, A. C. et al. (2014) Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC: Heart Failure, 2(2), pp. 187-197. (doi:10.1016/j.jchf.2014.01.001)

Ingle, L., Cleland, J. G. and Clark, A. L. (2014) The long-term prognostic significance of 6-minute walk test distance in patients with chronic heart failure. BioMed Research International, 2014, 505969. (doi:10.1155/2014/505969) (PMID:24800236) (PMCID:PMC3985138)

Gheorghiade, M. et al. (2014) Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions. Heart Failure Reviews, 19(2), pp. 135-152. (doi:10.1007/s10741-012-9361-8) (PMID:23099992) (PMCID:PMC4161017)

Perez, A. C., Jhund, P. S. , Stott, D. J., Gullestad, L., Cleland, J. G.F. , van Veldhuisen, D. J., Wikstrand, J., Kjekshus, J. and McMurray, J. J.V. (2014) Thyroid-stimulating hormone and clinical outcomes. JACC: Heart Failure, 2(1), pp. 35-40. (doi:10.1016/j.jchf.2013.07.008)

Cleland, J.G. et al. (2014) Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function (PROTECT) study. Circulation: Heart Failure, 7(1), pp. 76-87. (doi:10.1161/CIRCHEARTFAILURE.113.000284) (PMID:24281134)

Givertz, M.M. et al. (2014) Renal function trajectories and clinical outcomes in acute heart failure. Circulation: Heart Failure, 7(1), pp. 59-67. (doi:10.1161/CIRCHEARTFAILURE.113.000556) (PMID:24281137)

Dobre, D. et al. (2014) Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties. European Journal of Heart Failure, 16(1), pp. 76-85. (doi:10.1093/eurjhf/hft129) (PMID:23928650)

Bouri, S., Whinnett, Z. I., Cole, G. D., Manisty, C. H., Cleland, J. G.F. and Francis, D. P. (2014) Definitions of outcome, response and effect in imaging research to avoid confusion. JACC: Cardiovascular Imaging, 7(1), pp. 104-106. (doi:10.1016/j.jcmg.2013.11.001) (PMID:24433715)

Pellicori, P., Kallvikbacka-Bennett, A., Zhang, J., Khaleva, O., Warden, J., Clark, A. L. and Cleland, J. G.F. (2014) Revisiting a classical clinical sign: Jugular venous ultrasound. International Journal of Cardiology, 170(3), pp. 364-370. (doi:10.1016/j.ijcard.2013.11.015) (PMID:24315339)

Lewinter, C., Bland, J. M., Crouch, S., Cleland, J. G.F. , Doherty, P., LeWinter, M. M., Køber, L., Hall, A. S. and Gale, C. P. (2014) Impact of aspirin and statins on long-term survival in patients hospitalized with acute myocardial infarction complicated by heart failure: an analysis of 1706 patients. European Journal of Heart Failure, 16(1), pp. 95-102. (doi:10.1002/ejhf.40) (PMID:24453098)

Pellicori, P., Kallvikbacka-Bennett, A., Khaleva, O., Carubelli, V., Costanzo, P., Castiello, T., Wong, K., Zhang, J., Cleland, J. G.F. and Clark, A. L. (2014) Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification? International Journal of Cardiovascular Imaging, 30(1), pp. 69-79. (doi:10.1007/s10554-013-0310-y) (PMID:24150723)

Jacobs, L. et al. (2014) Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common database. Journal of Biomedical Research, 28(5), pp. 349-359. (doi:10.7555/JBR.28.20140045) (PMID:25332706) (PMCID:PMC4197385)

2013

Brignole, M. et al. (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace, 15(8), pp. 1070-1118. (doi:10.1093/europace/eut206)

Cleland, J. G. , Abraham, W. T., Linde, C., Gold, M. R., Young, J. B., Daubert, J. C., Sherfesee, L., Wells, G. A. and Tang, A. S.L. (2013) An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. European Heart Journal, 34(46), pp. 3547-3556. (doi:10.1093/eurheartj/eht290) (PMID:23900696) (PMCID:PMC3855551)

2012

Ingle, L., Sloan, R., Carroll, S., Goode, K., Cleland, J. G. and Clark, A. L. (2012) Influence of body mass on risk prediction during cardiopulmonary exercise testing in patients with chronic heart failure. Experimental and Clinical Cardiology, 17(4), pp. 179-182. (PMID:23592931) (PMCID:PMC3627270)

Pepera, G. K., Sandercock, G. R., Sloan, R., Cleland, J. J.F. , Ingle, L. and Clark, A. L. (2012) Influence of step length on 6-minute walk test performance in patients with chronic heart failure. Physiotherapy, 98(4), pp. 325-329. (doi:10.1016/j.physio.2011.08.005) (PMID:23122439)

Rho, R. W., Patton, K. K., Poole, J. E., Cleland, J. G. , Shadman, R., Anand, I., Maggioni, A. P., Carson, P. E., Swedberg, K. and Levy, W. C. (2012) Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator. Circulation, 126(20), pp. 2402-2407. (doi:10.1161/CIRCULATIONAHA.111.069245) (PMID:23072904)

Buga, L. and Cleland, J. G.F. (2012) Increasing knowledge and changing views in cardiac resynchronization therapy. Heart Failure Reviews, 17(6), pp. 721-725. (doi:10.1007/s10741-011-9281-z) (PMID:21932145)

Cleland, J. G.F. and Ghio, S. (2012) The determinants of clinical outcome and clinical response to CRT are not the same. Heart Failure Reviews, 17(6), pp. 755-766. (doi:10.1007/s10741-011-9268-9) (PMID:22081054)

Pellicori, P., Sherwi, N., Khaleva, O., Wong, K. and Cleland, J. G.F. (2012) An atrial mass: the value of echocardiographic three-dimensional reconstruction. Journal of Cardiovascular Medicine, 13(11), pp. 769-770. (doi:10.2459/JCM.0b013e32834917ed) (PMID:21709575)

Cleland, J. G.F. and Clark, A. L. (2012) Heart failure—does it matter whether LVEF is reduced? Lancet, 380(9851), pp. 1363-1365. (doi:10.1016/S0140-6736(12)61349-X) (PMID:22932711)

Manzano, L., Escobar, C., Cleland, J. G.F. and Flather, M. (2012) Diagnosis of elderly patients with heart failure. European Journal of Heart Failure, 14(10), pp. 1097-1103. (doi:10.1093/eurjhf/hfs109) (PMID:22771845)

Daubert, J.-C. et al. (2012) 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm, 9(9), pp. 1524-1576. (doi:10.1016/j.hrthm.2012.07.025) (PMID:22939223)

Storrow, A. B. et al. (2012) Standardized reporting criteria for studies evaluating suspected acute heart failure syndromes in the emergency department. Journal of the American College of Cardiology, 60(9), pp. 822-832. (doi:10.1016/j.jacc.2012.03.072) (PMID:22917006)

Kohan, D. E., Cleland, J. G. , Rubin, L. J., Theodorescu, D. and Barton, M. (2012) Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve? Life Sciences, 91(13-14), pp. 528-539. (doi:10.1016/j.lfs.2012.07.034) (PMID:22967485)

Oxberry, S. G., Bland, J. M., Clark, A. L., Cleland, J. G.F. and Johnson, M. J. (2012) Minimally clinically important difference in chronic breathlessness: Every little helps. American Heart Journal, 164(2), pp. 229-235. (doi:10.1016/j.ahj.2012.05.003) (PMID:22877809)

Poolsawad, N., Moore, L., Kambhampati, C. and Cleland, J.G.F. (2012) Handling Missing Values in Data Mining - A Case Study of Heart Failure Dataset. In: 9th International Conference on Fuzzy Systems and Knowledge Discovery (FSKD), Sichuan, China, 29-31 May 2012, pp. 2934-2938. ISBN 9781467300254 (doi:10.1109/FSKD.2012.6233860)

Bourantas, C. V. et al. (2012) Renal artery stenosis: an innocent bystander or an independent predictor of worse outcome in patients with chronic heart failure? A magnetic resonance imaging study. European Journal of Heart Failure, 14(7), pp. 764-772. (doi:10.1093/eurjhf/hfs057) (PMID:22508558)

Cullington, D., Goode, K. M., Clark, A. L. and Cleland, J. G.F. (2012) Heart rate achieved or beta-blocker dose in patients with chronic heart failure: which is the better target? European Journal of Heart Failure, 14(7), pp. 737-747. (doi:10.1093/eurjhf/hfs060) (PMID:22622001)

Ingle, L., Hobkirk, J., Damy, T., Nabb, S., Clark, A. L. and Cleland, J. G.F. (2012) Experiences of air travel in patients with chronic heart failure. International Journal of Cardiology, 158(1), pp. 66-70. (doi:10.1016/j.ijcard.2010.12.101) (PMID:21256607) (PMCID:PMC3387374)

Cleland, J. G.F. , Freemantle, N., Erdmann, E., Gras, D., Kappenberger, L., Tavazzi, L. and Daubert, J.-C. (2012) Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. European Journal of Heart Failure, 14(6), pp. 628-634. (doi:10.1093/eurjhf/hfs055) (PMID:22552183)

Cleland, J. G.F. , Mumtaz, S. and Cecchini, L. (2012) Role of antithrombotic agents in heart failure. Current Cardiology Reports, 14(3), pp. 314-325. (doi:10.1007/s11886-012-0266-x) (PMID:22467260)

O'Connor, C. M. et al. (2012) The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction. European Journal of Heart Failure, 14(6), pp. 605-612. (doi:10.1093/eurjhf/hfs029) (PMID:22535795)

Ingle, L., Cleland, J. G. and Clark, A. L. (2012) Body mass index is related to the perception of exertional breathlessness in patients presenting with dyspnoea of unknown origin. International Journal of Cardiology, 157(2), pp. 300-303. (doi:10.1016/j.ijcard.2012.03.113) (PMID:22483253)

Cleland, J. G.F. , Taylor, J., Freemantle, N., Goode, K. M., Rigby, A. S. and Tendera, M. (2012) Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study. European Journal of Heart Failure, 14(5), pp. 487-494. (doi:10.1093/eurjhf/hfs049) (PMID:22505395)

Cleland, J. G.F. (2012) Does aspirin really reduce the risk of colon cancer? Lancet, 379(9826), p. 1586. (doi:10.1016/S0140-6736(12)60671-0) (PMID:22541575)

Bourantas, C. V. et al. (2012) Atherosclerotic disease of the abdominal aorta and its branches: prognostic implications in patients with heart failure. Heart Failure Reviews, 17(2), pp. 229-239. (doi:10.1007/s10741-011-9284-9) (PMID:22002211)

Broch, K. et al. (2012) Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology. European Journal of Heart Failure, 14(3), pp. 268-277. (doi:10.1093/eurjhf/hfs006) (PMID:22302661)

Cleland, J. G.F. , Carubelli, V., Castiello, T., Yassin, A., Pellicori, P. and Antony, R. (2012) Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart Failure Reviews, 17(2), pp. 133-149. (doi:10.1007/s10741-012-9306-2) (PMID:22426973)

Damy, T. et al. (2012) Prevalence of, associations with, and prognostic value of Tricuspid Annular Plane Systolic Excursion (TAPSE) among out-patients referred for the evaluation of heart failure. Journal of Cardiac Failure, 18(3), pp. 216-225. (doi:10.1016/j.cardfail.2011.12.003) (PMID:22385942)

Teerlink, J. R. et al. (2012) The safety of an adenosine A1-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: Findings from PROTECT. Drug Safety, 35(3), pp. 233-244. (doi:10.2165/11594680-000000000-00000) (PMID:22339573)

Ardehali, H. et al. (2012) Targeting myocardial substrate metabolism in heart failure: potential for new therapies. European Journal of Heart Failure, 14(2), pp. 120-129. (doi:10.1093/eurjhf/hfr173) (PMID:22253453) (PMCID:PMC3260022)

Cleland, J. G.F. (2012) Systematic reporting bias in meta-analyses of trials of aspirin for the primary prevention of cardiovascular disease. American Journal of Medicine, 125(2), e13. (doi:10.1016/j.amjmed.2011.08.027) (PMID:22269629)

Costanzo, P., Cleland, J.G. , Atkin, S. L., Vassallo, E. and Perrone-Filardi, P. (2012) Use of carotid intima-media thickness regression to guide therapy and management of cardiac risks. Current Treatment Options in Cardiovascular Medicine, 14(1), pp. 50-56. (doi:10.1007/s11936-011-0158-1) (PMID:22139639)

Rossignol, P., Cleland, J. G.F. , Bhandari, S., Tala, S., Gustafsson, F., Fay, R., Lamiral, Z., Dobre, D., Pitt, B. and Zannad, F. (2012) Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study. Circulation, 125(2), pp. 271-279. (doi:10.1161/CIRCULATIONAHA.111.028282) (PMID:22128223)

Bogale, N. et al. (2012) The European CRT Survey: 1 year (9-15 months) follow-up results. European Journal of Heart Failure, 14(1), pp. 61-73. (doi:10.1093/eurjhf/hfr158) (PMID:22179034)

Lopez-Andrès, N., Rossignol, P., Iraqi, W., Fay, R., Nuée, J., Ghio, S., Cleland, J. G.F. , Zannad, F. and Lacolley, P. (2012) Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. European Journal of Heart Failure, 14(1), pp. 74-81. (doi:10.1093/eurjhf/hfr151) (PMID:22089058)

Gullestad, L. et al. (2012) Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). European Heart Journal, 33(18), pp. 2290-2296. (doi:10.1093/eurheartj/ehs077) (PMID:22513778)

Ingle, L., Sloan, R., Carroll, S., Goode, K., Cleland, J. G. and Clark, A. L. (2012) Abnormalities of the ventilatory equivalent for carbon dioxide in patients with chronic heart failure. Pulmonary Medicine, 2012, 589164. (doi:10.1155/2012/589164) (PMID:22619715) (PMCID:PMC3350981)

Zannad, F. et al. (2012) Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements? European Heart Journal, 33(9), pp. 1049-1057. (doi:10.1093/eurheartj/ehr437) (PMID:22422830)

2011

Cleland, J. G.F. , Coletta, A. P., Cullington, D., Castiello, T., de Boer, R. A. and Clark, A. L. (2011) Clinical trials update from the European Society of Cardiology Meeting 2011: ARISTOTLE, SMART-AV: QLV substudy, SHIFT: echocardiography and quality of life substudies, European CRT Survey, and Basic Science Update. European Journal of Heart Failure, 13(12), pp. 1376-1380. (doi:10.1093/eurjhf/hfr149) (PMID:22102626)

Damy, T. et al. (2011) Does the physical examination still have a role in patients with suspected heart failure? European Journal of Heart Failure, 13(12), pp. 1340-1348. (doi:10.1093/eurjhf/hfr128) (PMID:21990340)

Lewinter, C., Torp-Pedersen, C., Cleland, J. G.F. and Køber, L. (2011) Right and left bundle branch block as predictors of long-term mortality following myocardial infarction. European Journal of Heart Failure, 13(12), pp. 1349-1354. (doi:10.1093/eurjhf/hfr130) (PMID:22027083)

O'Connor, C. M. et al. (2011) Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the PROTECT pilot study. Circulation: Heart Failure, 4(6), pp. 724-732. (doi:10.1161/CIRCHEARTFAILURE.111.961581) (PMID:21900185)

Ariti, C. A., Cleland, J. G.F. , Pocock, S. J., Pfeffer, M. A., Swedberg, K., Granger, C. B., McMurray, J. J.V. , Michelson, E. L., Östergren, J. and Yusuf, S. (2011) Days alive and out of hospital and the patient journey in patients with heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. American Heart Journal, 162(5), pp. 900-906. (doi:10.1016/j.ahj.2011.08.003) (PMID:22093207)

Harinstein, M. E. et al. (2011) Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period. Heart, 97(19), pp. 1607-1618. (doi:10.1136/hrt.2011.222331) (PMID:21900586)

Cleland, J. G.F. , Coletta, A. P., Castiello, T. and Clark, A. L. (2011) Clinical trials update from the European Society of Cardiology Heart Failure meeting 2011: TEHAF, WHICH, CARVIVA, and atrial fibrillation in GISSI-HF and EMPHASIS-HF. European Journal of Heart Failure, 13(10), pp. 1147-1151. (doi:10.1093/eurjhf/hfr119) (PMID:21896537)

Anand, I. S. et al. (2011) Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Circulation: Heart Failure, 4(5), pp. 569-577. (doi:10.1161/CIRCHEARTFAILURE.111.962654) (PMID:21715583)

Costanzo, P., Cleland, J. G. , Vassallo, E. and Perrone-Filardi, P. (2011) Questioning the predictive role of carotid intima–media thickness. Future Cardiology, 7(5), pp. 651-656. (doi:10.2217/fca.11.44) (PMID:21929345)

Cleland, J. G.F. and Antony, R. (2011) It makes SENSE to take a safer road. European Heart Journal, 32(18), pp. 2225-2227. (doi:10.1093/eurheartj/ehr120) (PMID:21551157)

Inglis, S. C., Clark, R. A., McAlister, F. A., Stewart, S. and Cleland, J. G.F. (2011) Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. European Journal of Heart Failure, 13(9), pp. 1028-1040. (doi:10.1093/eurjhf/hfr039) (PMID:21733889)

Oxberry, S. G., Torgerson, D. J., Bland, J. M., Clark, A. L., Cleland, J. G.F. and Johnson, M. J. (2011) Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial. European Journal of Heart Failure, 13(9), pp. 1006-1012. (doi:10.1093/eurjhf/hfr068) (PMID:21712288)

Cleland, J. G.F. et al. (2011) The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet, 378(9792), pp. 676-683. (doi:10.1016/S0140-6736(11)61126-4) (PMID:21856481)

Cleland, J. G.F. , McDonagh, T. and Dargie, H. J. (2011) The authors' reply. Heart, 97(14), p. 1191. (doi:10.1136/heartjnl-2011-300372)

Cleland, J. G.F. and Freemantle, N. (2011) Revascularization for patients with heart failure. Inconsistencies between theory and practice. European Journal of Heart Failure, 13(7), pp. 694-697. (doi:10.1093/eurjhf/hfr075) (PMID:21712291)

Metra, M. et al. (2011) Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. European Heart Journal, 32(12), pp. 1519-1534. (doi:10.1093/eurheartj/ehr042) (PMID:21388992)

Voors, A. A. et al. (2011) Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). Journal of the American College of Cardiology, 57(19), pp. 1899-1907. (doi:10.1016/j.jacc.2010.11.057) (PMID:21545947)

Ingle, L., Sloan, R., Carroll, S., Goode, K., Cleland, J. G. and Clark, A. L. (2011) Prognostic significance of different measures of the ventilation-carbon dioxide relation in patients with suspected heart failure. European Journal of Heart Failure, 13(5), pp. 537-542. (doi:10.1093/eurjhf/hfq238) (PMID:21247919)

Villard, E. et al. (2011) A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. European Heart Journal, 32(9), pp. 1065-1076. (doi:10.1093/eurheartj/ehr105) (PMID:21459883) (PMCID:PMC3086901)

Cleland, J. G.F. , Coletta, A. P., Buga, L., Antony, R., Pellicori, P., Freemantle, N. and Clark, A. L. (2011) Clinical trials update from the American Heart Association Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT. European Journal of Heart Failure, 13(4), pp. 460-465. (doi:10.1093/eurjhf/hfr015) (PMID:21436363)

Inglis, S. C., Clark, R. A. and Cleland, J. G.F. (2011) Telemonitoring in patients with heart failure [2]. New England Journal of Medicine, 364(11), pp. 1078-1080. (doi:10.1056/NEJMc1100395) (PMID:21410377)

Shelton, R. J., Brown, B. D., Allinson, A., Johnson, T., Smales, C., Jolly, S. and Cleland, J. G.F. (2011) A comparison between monophasic and biphasic defibrillation for the cardioversion of persistent atrial fibrillation in patients with and without heart failure. International Journal of Cardiology, 147(3), pp. 405-408. (doi:10.1016/j.ijcard.2009.09.545) (PMID:19861229)

Cleland, J. G.F. , Calvert, M., Freemantle, N., Arrow, Y., Ball, S. G., Bonser, R. S., Chattopadhyay, S., Norell, M. S., Pennell, D. J. and Senior, R. (2011) The Heart Failure Revascularisation Trial (HEART). European Journal of Heart Failure, 13(2), pp. 227-233. (doi:10.1093/eurjhf/hfq230) (PMID:21156659)

Frankenstein, L., Goode, K., Ingle, L., Remppis, A., Schellberg, D., Nelles, M., Katus, H.A., Clark, A.L., Cleland, J.G.F. and Zugck, C. (2011) Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status – Do we need specificity for sex and beta-blockers? International Journal of Cardiology, 147(1), pp. 74-78. (doi:10.1016/j.ijcard.2009.08.005) (PMID:19765836)

Bourantas, C. V. et al. (2011) Relationship between right ventricular volumes measured by cardiac magnetic resonance imaging and prognosis in patients with chronic heart failure. European Journal of Heart Failure, 13(1), pp. 52-60. (doi:10.1093/eurjhf/hfq161) (PMID:20930000)

Bogale, N., Witte, K., Priori, S., Cleland, J. , Auricchio, A., Gadler, F., Gitt, A., Limbourg, T., Linde, C. and Dickstein, K. (2011) The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. European Journal of Heart Failure, 13(9), pp. 974-983. (doi:10.1093/eurjhf/hfr085) (PMID:21771823)

Bourantas, C. V. et al. (2011) Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: A cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance, 13(1), 53. (doi:10.1186/1532-429X-13-53) (PMID:21936915) (PMCID:PMC3190338)

Cleland, J. G.F. , Coletta, A. P., Freemantle, N. and Clark, A. L. (2011) Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II. European Journal of Heart Failure, 13(7), pp. 805-808. (doi:10.1093/eurjhf/hfr077) (PMID:21712293)

Cleland, J. G.F. , McDonagh, T., Rigby, A. S., Yassin, A., Whittaker, T. and Dargie, H. J. (2011) The national heart failure audit for England and Wales 2008-2009. Heart, 97(11), pp. 876-886. (doi:10.1136/hrt.2010.209171) (PMID:21173198)

Cullington, D., Esmail, S., Hurren, S., Cleland, J.G.F. , Clark, A. L. and Alamgir, M. F. (2011) Unmasking the truth. BMJ Case Reports, 2011, bcr0720103. (doi:10.1136/bcr.07.2010.3193)

Cullington, D., Goode, K. M., Cleland, J. G.F. and Clark, A. L. (2011) Limited role for ivabradine in the treatment of chronic heart failure. Heart, 97(23), pp. 1961-1966. (doi:10.1136/heartjnl-2011-300041) (PMID:21917660)

Futter, J. E., Cleland, J. G.F. and Clark, A. L. (2011) Body mass indices and outcome in patients with chronic heart failure. European Journal of Heart Failure, 13(2), pp. 207-213. (doi:10.1093/eurjhf/hfq218) (PMID:21138908)

2010

Massie, B. M. et al. (2010) Rolofylline, an adenosine A1−receptor antagonist, in acute heart failure. New England Journal of Medicine, 363(15), pp. 1419-1428. (doi:10.1056/NEJMoa0912613) (PMID:20925544)

2009

Cleland, J. et al. (2009) Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). Journal of the American College of Cardiology, 54(20), pp. 1850-1859. (doi:10.1016/j.jacc.2009.06.041)

2008

Coletta, A. P., Cleland, J. G.F. , Cullington, D. and Clark, A. L. (2008) Clinical trials update from heart rhythm 2008 and heart failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452. European Journal of Heart Failure, 10(9), pp. 917-920. (doi:10.1016/j.ejheart.2008.07.006) (PMID:18678526)

Coletta, A. P., Cullington, D., Clark, A. L. and Cleland, J. G.F. (2008) Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF. European Journal of Heart Failure, 10(12), pp. 1264-1267. (doi:10.1016/j.ejheart.2008.10.002) (PMID:19008149)

Cleland, J. G.F. , Coletta, A. P., Yassin, A., Hado, H., Cullington, D., Abdellah, A. T. and Clark, A. L. (2008) Clinical trials update from the American College of Cardiology 2008: carisma, trends, meta-analysis of cox-2 studies, hat, on-target, hyvet, accomplish, momentum, protect, horizon-hf and reverse. European Journal of Heart Failure, 10(6), pp. 614-620. (doi:10.1016/j.ejheart.2008.05.003) (PMID:18502685)

Goode, K. M., Nabb, S., Cleland, J. G.F. and Clark, A. L. (2008) A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic. Journal of Cardiac Failure, 14(5), pp. 379-387. (doi:10.1016/j.cardfail.2008.01.014) (PMID:18514929)

Pang, P. S. et al. (2008) A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. European Heart Journal, 29(6), pp. 816-824. (doi:10.1093/eurheartj/ehn048) (PMID:18310669)

Cleland, J. G.F. , Coletta, A. P., Abdellah, A. T., Cullington, D., Clark, A. L. and Rigby, A. S. (2008) Clinical trials update from the American Heart Association 2007: CORONA, Rethin0, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy. European Journal of Heart Failure, 10(1), pp. 102-108. (doi:10.1016/j.ejheart.2007.12.004) (PMID:18179987)

Cleland, J. G.F. (2008) Classification of the level of evidence in international guidelines for acute and chronic heart failure. Acute Heart Failure, pp. 885-891. (doi:10.1007/978-1-84628-782-4_82)

Cleland, J. G.F. (2008) The epidemiology of heart failure. In: Beattie, J. and Goodlin, S. (eds.) Supportive Care in Heart Failure. Oxford University Press: Oxford, pp. 9-26. ISBN 9780198570288 (doi:10.1093/acprof:oso/9780198570288.003.0002)

2005

Cleland, J. G.F. , Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L. and Tavazzi, L. (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352(15), pp. 1539-1549. (doi:10.1056/NEJMoa050496) (PMID:15753115)

2003

Cleland, J.G.F. , Pennell, D.J., Ray, S.G., Coats, A.J., Macfarlane, P.W., Murray, G.D., Mule, J.D., Vered, Z. and Lahiri, A. (2003) Myocardial viability as a determinant of the ejection fraction response to Carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet, 362(9377), pp. 14-21. (doi:10.1016/S0140-6736(03)13801-9) (PMID:12853194)

Poole-Wilson, P. A. et al. (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet, 362(9377), pp. 7-13. (doi:10.1016/S0140-6736(03)13800-7) (PMID:12853193)

2002

Cleland, J. G.F. et al. (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet, 360(9346), pp. 1631-1639. (doi:10.1016/S0140-6736(02)11601-1) (PMID:12457785)

Follath, F. et al. (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet, 360(9328), pp. 196-202. (doi:10.1016/S0140-6736(02)09455-2) (PMID:12133653)

This list was generated on Fri Aug 18 10:41:20 2017 BST.
Number of items: 246.

Articles

Cleland, J. G.F. (2017) What do cardiology and homeopathy have in common? : A belief in aspirin? JACC: Heart Failure, 5(8), pp. 611-614. (doi:10.1016/j.jchf.2017.06.009) (PMID:28774397)

Gimpelewicz, C. et al. (2017) Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: a subgroup analysis from the RELAX-AHF trial. American Heart Journal, 190, pp. 113-122. (doi:10.1016/j.ahj.2017.05.012)

Halliday, B. P., Cleland, J. G.F. , Goldberger, J. J. and Prasad, S. K. (2017) Personalizing sudden death risk stratification in dilated cardiomyopathy: past, present and future. Circulation, 136(2), pp. 215-231. (doi:10.1161/CIRCULATIONAHA.116.027134) (PMID:28696268)

Damman, K. et al. (2017) Plasma neutrophil gelatinase-associated lipocalin and predicting clinically relevant worsening renal function in acute heart failure. International Journal of Molecular Sciences, 18(7), 1470. (doi:10.3390/ijms18071470) (PMID:28698481)

Shen, L. et al. (2017) Declining risk of sudden death in heart failure. New England Journal of Medicine, 377(1), pp. 41-51. (doi:10.1056/NEJMoa1609758) (PMID:28679089)

Cleland, J. G.F. , Pellicori, P., Clark, A. L. and Petrie, M. C. (2017) Time to take the failure out of heart failure: the importance of optimism. JACC: Heart Failure, 5(7), pp. 538-540. (doi:10.1016/j.jchf.2017.04.003) (PMID:28624485)

Pellicori, P., Clark, A. L., Kallvikbacka-Bennett, A., Zhang, J., Urbinati, A., Monzo, L., Dierckx, R., Anker, S. D. and Cleland, J. G.F. (2017) Non-invasive measurement of right atrial pressure by near-infrared spectroscopy: preliminary experience. A report from the SICA-HF study. European Journal of Heart Failure, 19(7), pp. 883-892. (doi:10.1002/ejhf.825) (PMID:28387033)

Liu, L. C.Y. et al. (2017) Identifying subpopulations with distinct response to treatment using plasma biomarkers in acute heart failure: results from the PROTECT trial. Cardiovascular Drugs and Therapy, (doi:10.1007/s10557-017-6726-1) (PMID:28656542) (Early Online Publication)

Sharma, A. et al. (2017) A network analysis to compare biomarker profiles in patients with and without diabetes mellitus in acute heart failure. European Journal of Heart Failure, (doi:10.1002/ejhf.912) (PMID:28639369) (Early Online Publication)

Kotecha, D. et al. (2017) Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis. Journal of the American College of Cardiology, 69(24), pp. 2885-2896. (doi:10.1016/j.jacc.2017.04.001) (PMID:28467883)

McCoy, J. et al. (2017) Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients. Open Heart, (Accepted for Publication)

Ferreira, J. P. et al. (2017) Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF. European Journal of Heart Failure, (doi:10.1002/ejhf.900) (PMID:28580625) (Early Online Publication)

Fröhlich, H. et al. (2017) Comparative effectiveness of enalapril, lisinopril and ramipril in the treatment of patients with chronic heart failure. A propensity score matched cohort study. European Heart Journal: Cardiovascular Pharmacotherapy, (doi:10.1093/ehjcvp/pvx013) (PMID:28475676) (Early Online Publication)

Jacobs, L. et al. (2017) Risk for incident heart failure: a subject-level meta-analysis from the Heart “OMics” in AGEing (HOMAGE) study. Journal of the American Heart Association, 6(5), e005231. (doi:10.1161/JAHA.116.005231) (PMID:28465299)

Zhang, J., Wong, K. Y.-K., Clark, A. L. and Cleland, J. G.F. (2017) Exploring the relation between changes in NT-proBNP and renal function in patients with suspected heart failure using structural equation modelling. International Journal of Cardiology, 233, pp. 67-72. (doi:10.1016/j.ijcard.2017.01.127) (PMID:28169056)

Fröhlich, H. et al. (2017) Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clinical Research in Cardiology, (Accepted for Publication)

McDiarmid, A. K., Pellicori, P., Cleland, J. G.F. and Plein, S. (2017) Taxonomy of segmental myocardial systolic dysfunction. European Heart Journal, 38(13), pp. 942-954. (doi:10.1093/eurheartj/ehw140) (PMID:27147609) (PMCID:PMC5381597)

Brown, D. A. et al. (2017) Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nature Reviews Cardiology, 14, pp. 238-250. (doi:10.1038/nrcardio.2016.203) (PMID:28004807)

Cleland, J. G.F. and Mueller, C. (2017) What can we learn from SOCRATES: more questions than answers? European Heart Journal, 38(15), pp. 1128-1131. (doi:10.1093/eurheartj/ehw561) (PMID:28204466)

Nymo, S. H. et al. (2017) Limited added value of circulating inflammatory biomarkers in chronic heart failure. JACC: Heart Failure, 5(4), pp. 256-264. (doi:10.1016/j.jchf.2017.01.008) (PMID:28359413)

Skobel, E. et al. (2017) Internet-based training of coronary artery patients: the Heart Cycle Trial. Heart and Vessels, 32(4), pp. 408-418. (doi:10.1007/s00380-016-0897-8) (PMID:27730298)

Halliday, B. P. et al. (2017) Association between mid-wall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation, (doi:10.1161/CIRCULATIONAHA.116.026910) (PMID:28351901) (Early Online Publication)

Salvi, D. et al. (2017) An m-health system for education and motivation in cardiac rehabilitation: the experience of heartcycle guided exercise. Journal of Telemedicine and Telecare, (doi:10.1177/1357633X17697501) (PMID:28350282) (Early Online Publication)

Liu, L. C.Y. et al. (2017) Plasma biomarkers to determine individual response to rolofylline in acute heart failure: results from the PROTECT trial. Cardiovascular Drugs and Therapy, (Accepted for Publication)

Rao, M. P. et al. (2017) Sudden cardiac death in patients with ischemic heart failure undergoing coronary artery bypass grafting results from the STICH randomized clinical trial (Surgical Treatment for Ischemic Heart Failure). Circulation, 135, pp. 1136-1144. (doi:10.1161/CIRCULATIONAHA.116.026075) (PMID:28154006)

Dovancescu, S., Pellicori, P., Mabote, T., Torabi, A., Clark, A. L. and Cleland, J. G.F. (2017) The effects of short-term omission of daily medication on the pathophysiology of heart failure. European Journal of Heart Failure, (doi:10.1002/ejhf.748) (PMID:28295907)

Linde, C., Abraham, W. T., Gold, M. R., Daubert, C., Tang, A. S.L., Young, J. B., Sherfesee, L., Hudnall, H., Fagan, D. H. and Cleland, J. G. (2017) Predictors of short-term clinical response to cardiac resynchronization therapy. European Journal of Heart Failure, (doi:10.1002/ejhf.795) (PMID:28295869) (Early Online Publication)

Ouwerkerk, W. et al. (2017) Determinants and clinical outcome of uptitration of ACE-inhibitor and beta-blocker in patients with heart failure: a prospective European study. European Heart Journal, (doi:10.1093/eurheartj/ehx026) (PMID:28329163) (Early Online Publication)

Cleland, J. G.F. et al. (2017) Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). European Journal of Heart Failure, (doi:10.1002/ejhf.786) (PMID:28296139) (Early Online Publication)

Fröhlich, H. et al. (2017) Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure. International Journal of Cardiology, (doi:10.1016/j.ijcard.2017.03.028) (PMID:28342630) (In Press)

Filippatos, G. S. et al. (2017) Independent academic data monitoring committees for clinical trials in cardiovascular and cardiometabolic diseases. European Journal of Heart Failure, (doi:10.1002/ejhf.761) (PMID:28271595) (Early Online Publication)

Demissei, B. G. et al. (2017) Plasma biomarkers to predict or rule out early post-discharge events in patients discharged after an acute heart failure hospital admission. European Journal of Heart Failure, (doi:10.1002/ejhf.766) (PMID:28251755) (Early Online Publication)

Voors, A. A. et al. (2017) Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. European Journal of Heart Failure, (doi:10.1002/ejhf.785) (PMID:28247565) (Early Online Publication)

Dierckx, R., Inglis, S. C., Clark, R. A., Prieto-Merino, D. and Cleland, J. G.F. (2017) Telemedicine in heart failure: new insights from the Cochrane meta-analyses. European Journal of Heart Failure, 19(3), pp. 304-306. (doi:10.1002/ejhf.759) (PMID:28251777)

Masters, J., Morton, G., Anton, I., Szymanski, J., Greenwood, E., Grogono, J., Flett, A. S., Cleland, J. G.F. and Cowburn, P. J. (2017) Specialist intervention is associated with improved patient outcomes in patients with decompensated heart failure: evaluation of the impact of a multidisciplinary inpatient heart failure team. Open Heart, 4(1), e000547. (doi:10.1136/openhrt-2016-000547)

Matsue, Y. et al. (2017) Clinical correlates and prognostic value of proenkephalin in acute and chronic heart failure. Journal of Cardiac Failure, 23(3), pp. 231-239. (doi:10.1016/j.cardfail.2016.09.007) (PMID:27663098)

Matsue, Y. et al. (2017) Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure. Heart, 103(6), pp. 407-413. (doi:10.1136/heartjnl-2016-310112) (PMID:27658757)

Pellicori, P., Urbinati, A., Shah, P., MacNamara, A., Kazmi, S., Dierckx, R., Zhang, J., Cleland, J. G.F. and Clark, A. L. (2017) What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan? European Journal of Heart Failure, (doi:10.1002/ejhf.788) (PMID:28244205) (Early Online Publication)

Zakeri, R. et al. (2017) The burden of proof: the current state of atrial fibrillation prevention and treatment trials. Heart Rhythm, (doi:10.1016/j.hrthm.2017.01.032) (PMID:28161513) (In Press)

Emdin, C. A. et al. (2017) Referral for specialist follow-up and its association with post-discharge mortality among patients with systolic heart failure (from the National Heart Failure Audit for England and Wales). American Journal of Cardiology, 119(3), pp. 440-444. (doi:10.1016/j.amjcard.2016.10.021) (PMID:27884420)

Gastelurrutia, P., Lupón, J., Domingo, M., Stut, W., Dovancescu, S., Cleland, J. , Frankenstein, L. and Bayes-Genis, A. (2017) Potential role for clinical calibration to increase engagement with and application of home telemonitoring: a report from the HeartCycle programme. ESC Heart Failure, 4(1), pp. 66-70. (doi:10.1002/ehf2.12104) (PMID:28217314) (PMCID:PMC5292630)

Zhang, J., Dierckx, R., Mohee, K., Clark, A. L. and Cleland, J. G.F. (2017) Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis. ESC Heart Failure, 4(1), pp. 40-45. (doi:10.1002/ehf2.12112) (PMID:28217311) (PMCID:PMC5292634)

Streng, K. W. et al. (2017) Associations of body mass index with laboratory and biomarkers in patients with acute heart failure. Circulation: Heart Failure, 10(1), e003350. (doi:10.1161/CIRCHEARTFAILURE.116.003350) (PMID:28069685)

Tromp, J. et al. (2017) Serum potassium levels and outcome in acute heart failure (data from the PROTECT and COACH trials). American Journal of Cardiology, 119(2), pp. 290-296. (doi:10.1016/j.amjcard.2016.09.038) (PMID:27823598)

Arain, F., Gullestad, L., Nymo, S., Kjekshus, J., Cleland, J. G.F. , Michelsen, A., McMurray, J. J.V. , Wikstrand, J., Aukrust, P. and Ueland, T. (2017) Low YKL-40 in Chronic Heart Failure may predict beneficial effects of statins: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Biomarkers, 22, pp. 261-267. (doi:10.1080/1354750X.2016.1204003) (PMID:27325138)

Ritchie, J. et al. (2017) Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial. Nephrology Dialysis Transplantation, 32(6), pp. 1006-1013. (doi:10.1093/ndt/gfw107)

Torabi, A. et al. (2016) Influence of case definition on incidence and outcome of acute coronary syndromes. Open Heart, 3(2), e000487. (doi:10.1136/openhrt-2016-000487)

Koudstaal, S. et al. (2016) Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. European Journal of Heart Failure, (doi:10.1002/ejhf.709) (PMID:28008698) (Early Online Publication)

Cleland, J. G.F. (2016) Does aspirin detract from the benefits of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction? Probably! European Journal of Heart Failure, (doi:10.1002/ejhf.697) (PMID:27943554) (Early Online Publication)

Teerlink, J. R. et al. (2016) Chronic oral study of myosin activation to increase contractility in heart failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial. Lancet, 388(10062), pp. 2895-2903. (doi:10.1016/S0140-6736(16)32049-9)

Vegter, E. L. et al. (2016) Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure. International Journal of Cardiology, 224, pp. 231-239. (doi:10.1016/j.ijcard.2016.09.010) (PMID:27661412)

Pellicori, P., Cleland, J. G.F. , Zhang, J., Kallvikbacka-Bennett, A., Urbinati, A., Shah, P., Kazmi, S. and Clark, A. L. (2016) Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure. Cardiovascular Drugs and Therapy, 30(6), pp. 599-609. (doi:10.1007/s10557-016-6697-7) (PMID:27819111)

Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D. and Cleland, J. G.F. (2016) Structured telephone support or non-invasive telemonitoring for patients with heart failure. Heart, 103(4), pp. 255-257. (doi:10.1136/heartjnl-2015-309191) (PMID:27864319)

Demissei, B. G. et al. (2016) Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure — Post-hoc analysis of the PROTECT trial. International Journal of Cardiology, 223, pp. 967-975. (doi:10.1016/j.ijcard.2016.08.271) (PMID:27589047)

Ferreira, J. P. et al. (2016) Renal function estimation and Cockroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: the Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives. BMC Medicine, 14, 181. (doi:10.1186/s12916-016-0731-2) (PMID:27829460) (PMCID:PMC5103492)

Bekfani, T. et al. (2016) Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life. International Journal of Cardiology, 222, pp. 41-46. (doi:10.1016/j.ijcard.2016.07.135) (PMID:27454614)

Tromp, J. et al. (2016) Acute heart failure in the young: clinical characteristics and biomarker profiles. International Journal of Cardiology, 221, pp. 1067-1072. (doi:10.1016/j.ijcard.2016.06.339) (PMID:27448534)

Sokoreli, I. et al. (2016) Depression as an independent prognostic factor for all-cause mortality after a hospital admission for worsening heart failure. International Journal of Cardiology, 220, pp. 202-207. (doi:10.1016/j.ijcard.2016.06.068) (PMID:27389442)

Cotter, G. et al. (2016) Predictors and associations with outcomes of length of hospital stay in patients with acute heart failure: results from VERITAS. Journal of Cardiac Failure, 22(10), pp. 815-822. (doi:10.1016/j.cardfail.2015.12.017) (PMID:26721775)

ter Maaten, J. M. et al. (2016) Hypochloremia, diuretic resistance, and outcome in patients with acute heart failure. Circulation: Heart Failure, 9(8), e003109. (doi:10.1161/CIRCHEARTFAILURE.116.003109) (PMID:27507112)

Bhattacharyya, S., Mittal, T., Abayalingam, M., Kabir, T., Dalby, M., Cleland, J. G.F. , Baltabaeva, A. and Rahman Haley, S. (2016) Classification of aortic stenosis by flow and gradient patterns provides insights into the pathophysiology of disease. Angiology, 67(7), pp. 664-669. (doi:10.1177/0003319715611804) (PMID:26475710)

Cleland, J. G.F. , Zhang, J., Pellicori, P., Dicken, B., Dierckx, R., Shoaib, A., Wong, K., Rigby, A., Goode, K. and Clark, A. L. (2016) Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiology, 1(5), pp. 539-547. (doi:10.1001/jamacardio.2016.1161) (PMID:27439011)

Davison, B. A. et al. (2016) Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. European Journal of Heart Failure, 18(8), pp. 1041-1050. (doi:10.1002/ejhf.540) (PMID:27114058)

Fröhlich, H. et al. (2016) Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease. American Heart Journal, 178, pp. 28-36. (doi:10.1016/j.ahj.2016.03.024) (PMID:27502849)

Ponikowski, P. et al. (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Journal of Heart Failure, 18(8), pp. 891-975. (doi:10.1002/ejhf.592) (PMID:27207191)

Biegus, J. et al. (2016) Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. European Journal of Heart Failure, 18(7), pp. 830-839. (doi:10.1002/ejhf.532) (PMID:27170455)

Feldman, T. et al. (2016) Transcatheter interatrial shunt device for the treatment of heart failure: rationale and design of the randomized trial to REDUCE elevated left atrial pressure in heart failure (REDUCE LAP-HF I). Circulation: Heart Failure, 9(7), e003025. (doi:10.1161/CIRCHEARTFAILURE.116.003025) (PMID:27330010)

Emmens, J. E. et al. (2016) Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome. European Journal of Heart Failure, 18(6), pp. 641-649. (doi:10.1002/ejhf.426) (PMID:26511274)

Voors, A. A. et al. (2016) A systems BIOlogy Study to TAilored treatment in chronic heart failure: rationale, design, and baseline characteristics of BIOSTAT-CHF. European Journal of Heart Failure, 18(6), pp. 716-726. (doi:10.1002/ejhf.531) (PMID:27126231)

ter Maaten, J. M. et al. (2016) Combining diuretic response and hemoconcentration to predict rehospitalization after admission for acute heart failure. Circulation: Heart Failure, 9(6), e002845. (doi:10.1161/CIRCHEARTFAILURE.115.002845) (PMID:27266853)

Pellicori, P., Goode, K. M., Nicholls, R., Ahmed, D., Clark, A. L. and Cleland, J. G.F. (2016) Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurements. International Journal of Cardiology, 210, pp. 149-155. (doi:10.1016/j.ijcard.2016.02.081) (PMID:26946041)

Gheorghiade, M. et al. (2016) Developing new treatments for heart failure: focus on the heart. Circulation: Heart Failure, 9(5), e002727. (doi:10.1161/CIRCHEARTFAILURE.115.002727) (PMID:27166246)

Shoaib, A. et al. (2016) Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1. European Journal of Heart Failure, 18(5), pp. 556-563. (doi:10.1002/ejhf.505) (PMID:26991150)

Kotecha, D. et al. (2016) Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. BMJ, 353, i1855. (doi:10.1136/bmj.i1855) (PMID:27098105) (PMCID:PMC4849174)

Ovchinnikova, E. S. et al. (2016) Signature of circulating microRNAs in patients with acute heart failure. European Journal of Heart Failure, 18(4), pp. 414-423. (doi:10.1002/ejhf.332) (PMID:26345695)

Teerlink, J. R. et al. (2016) Acute treatment with omecamtiv mecarbil to increase contractility in acute heart failure. Journal of the American College of Cardiology, 67(12), pp. 1444-1455. (doi:10.1016/j.jacc.2016.01.031) (PMID:27012405)

Hasenfuß, G. et al. (2016) A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet, 387(10025), pp. 1298-1304. (doi:10.1016/S0140-6736(16)00704-2) (PMID:27025436)

Damman, K., Kjekshus, J., Wikstrand, J., Cleland, J. G.F. , Komajda, M., Wedel, H., Waagstein, F. and McMurray, J. J.V. (2016) Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure, 18(3), pp. 328-336. (doi:10.1002/ejhf.462) (PMID:26693947)

Demissei, B. G. et al. (2016) Optimizing clinical use of biomarkers in high-risk acute heart failure patients. European Journal of Heart Failure, 18(3), pp. 269-280. (doi:10.1002/ejhf.443) (PMID:26634889)

Cuba Gyllensten, I., Bonomi, A. G., Goode, K. M., Reiter, H., Habetha, J., Amft, O. and Cleland, J. G.F. (2016) Early indication of decompensated heart failure in patients on home-telemonitoring: a comparison of prediction algorithms based on daily weight and noninvasive transthoracic bio-impedance. JMIR Medical Informatics, 4(1), e3. (doi:10.2196/medinform.4842) (PMID:26892844) (PMCID:PMC4777885)

Demissei, B. G. et al. (2016) Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients. International Journal of Cardiology, 204, pp. 164-171. (doi:10.1016/j.ijcard.2015.11.141) (PMID:26666342)

Bhandari, S., Ives, N., Brettell, E. A., Valente, M., Cockwell, P., Topham, P. S., Cleland, J. G.F. , Khwaja, A. and El Nahas, M. (2016) Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial. Nephrology Dialysis Transplantation, 31(2), pp. 255-261. (doi:10.1093/ndt/gfv346) (PMID:26429974) (PMCID:PMC4725389)

ter Maaten, J. M. et al. (2016) A combined clinical and biomarker approach to predict diuretic response in acute heart failure. Clinical Research in Cardiology, 105(2), pp. 145-153. (doi:10.1007/s00392-015-0896-2) (PMID:26280875) (PMCID:PMC4735256)

Bruno, N. et al. (2016) MicroRNAs relate to early worsening of renal function in patients with acute heart failure. International Journal of Cardiology, 203, pp. 564-569. (doi:10.1016/j.ijcard.2015.10.217) (PMID:26569364)

Zhang, J., Hobkirk, J., Carroll, S., Pellicori, P., Clark, A. L. and Cleland, J. G.F. (2016) Exploring quality of life in patients with and without heart failure. International Journal of Cardiology, 202, pp. 676-684. (doi:10.1016/j.ijcard.2015.09.076) (PMID:26453816)

Cowie, M. R., Bax, J., Bruining, N., Cleland, J. G.F. , Koehler, F., Malik, M., Pinto, F., van der Velde, E. and Vardas, P. (2016) e-Health: a position statement of the European Society of Cardiology. European Heart Journal, 37(1), pp. 63-66. (doi:10.1093/eurheartj/ehv416) (PMID:26303835)

Emdin, C. A. et al. (2016) Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales. Heart, 103(1), pp. 55-62. (doi:10.1136/heartjnl-2016-309706) (PMID:27530132)

Ponikowski, P. et al. (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 37(27), pp. 2129-2200. (doi:10.1093/eurheartj/ehw128) (PMID:27206819)

Cleland, J. G.F. and Mareev, Y. (2015) CRT for heart failure and ESRD: more trials or more thought needed? Journal of the American College of Cardiology, 66(23), pp. 2630-2632. (doi:10.1016/j.jacc.2015.10.022) (PMID:26670063)

Jolicœur, E. M. et al. (2015) Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction. Journal of the American College of Cardiology, 66(19), pp. 2092-2100. (doi:10.1016/j.jacc.2015.08.882) (PMID:26541919)

Pellicori, P., Joseph, A. C., Zhang, J., Lukaschuk, E., Sherwi, N., Bourantas, C. V., Loh, H., Clark, A. L. and Cleland, J. G.F. (2015) The relationship of QRS morphology with cardiac structure and function in patients with heart failure. Clinical Research in Cardiology, 104(11), pp. 935-945. (doi:10.1007/s00392-015-0861-0) (PMID:25903113)

Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D. and Cleland, J. G.F. (2015) Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database of Systematic Reviews, 2015(10), CD007228. (doi:10.1002/14651858.CD007228.pub3) (PMID:26517969)

Farag, M., Mabote, T., Shoaib, A., Zhang, J., Nabhan, A. F., Clark, A. L. and Cleland, J. G. (2015) Hydralazine and nitrates alone or combined for the management of chronic heart failure: a systematic review. International Journal of Cardiology, 196, pp. 61-69. (doi:10.1016/j.ijcard.2015.05.160) (PMID:26073215)

Mareev, Y. and Cleland, J. G.F. (2015) Should β-blockers be used in patients with heart failure and atrial fibrillation? Clinical Therapeutics, 37(10), pp. 2215-2224. (doi:10.1016/j.clinthera.2015.08.017) (PMID:26391145)

Butcher, C., Mareev, Y., Markides, V., Mason, M., Wong, T. and Cleland, J.G.F. (2015) Cardiac resynchronization therapy update: evolving indications, expanding benefit? Current Cardiology Reports, 17(10), 90. (doi:10.1007/s11886-015-0641-5) (PMID:26298308)

Frankenstein, L., Fröhlich, H. and Cleland, J. G.F. (2015) Multidisciplinary approach for patients hospitalized with heart failure. Revista Española de Cardiología (English Edition), 68(10), pp. 885-891. (doi:10.1016/j.rec.2015.05.008) (PMID:26409892)

Shadman, R. et al. (2015) A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model. Heart Rhythm, 12(10), pp. 2069-2077. (doi:10.1016/j.hrthm.2015.06.039) (PMID:26142301)

Cleland, J. G.F. and Freemantle, N. (2015) QRS morphology as a predictor of the response to cardiac resynchronisation therapy: fact or fashion? Heart, 101(18), pp. 1441-1443. (doi:10.1136/heartjnl-2015-307553) (PMID:26187602)

Damy, T. et al. (2015) Development of a human model for the study of effects of hypoxia, exercise, and sildenafil on cardiac and vascular function in chronic heart failure. Journal of Cardiovascular Pharmacology, 66(3), pp. 229-238. (doi:10.1097/FJC.0000000000000262) (PMID:25874853)

Dierckx, R., Cleland, J. G.F. , Pellicori, P., Zhang, J., Goode, K., Putzu, P., Boyalla, V. and Clark, A. L. (2015) If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment? Journal of Telemedicine and Telecare, 21(6), pp. 331-339. (doi:10.1177/1357633X15574947) (PMID:25766855)

Stut, W., Deighan, C., Cleland, J. G. and Jaarsma, T. (2015) Adherence to self-care in patients with heart failure in the HeartCycle study. Patient Preference and Adherence, 9, pp. 1195-1206. (doi:10.2147/PPA.S88482) (PMID:26316725) (PMCID:PMC4548736)

Askevold, E. T., Gullestad, L., Nymo, S., Kjekshus, J., Yndestad, A., Latini, R., Cleland, J. G.F. , McMurray, J. J.V. , Aukrust, P. and Ueland, T. (2015) Secreted frizzled related protein 3 in chronic heart failure: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA). PLoS ONE, 10(8), e0133970. (doi:10.1371/journal.pone.0133970) (PMID:26288364) (PMCID:PMC4545831)

Cleland, J. G.F. , Mareev, Y. and Linde, C. (2015) Reflections on EchoCRT: sound guidance on QRS duration and morphology for CRT? European Heart Journal, 36(30), pp. 1948-1951. (doi:10.1093/eurheartj/ehv264) (PMID:26180135)

Raphael, C. E., Finegold, J. A., Barron, A. J., Whinnett, Z. I., Mayet, J., Linde, C., Cleland, J. G.F. , Levy, W. C. and Francis, D. P. (2015) The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most? European Heart Journal, 36(26), pp. 1676-1688. (doi:10.1093/eurheartj/ehv102) (PMID:25908776)

Ferrari, R., Böhm, M., Cleland, J. G.F. , Paulus, W. J.S., Pieske, B., Rapezzi, C. and Tavazzi, L. (2015) Heart failure with preserved ejection fraction: uncertainties and dilemmas. European Journal of Heart Failure, 17(7), pp. 665-671. (doi:10.1002/ejhf.304) (PMID:26079097)

Mentz, R. J. et al. (2015) Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial. European Journal of Heart Failure, 17(7), pp. 697-706. (doi:10.1002/ejhf.308) (PMID:26083764)

Pellicori, P., Kallvikbacka-Bennett, A., Dierckx, R., Zhang, J., Putzu, P., Cuthbert, J., Boyalla, V., Shoaib, A., Clark, A. L. and Cleland, J. G.F. (2015) Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure. Heart, 101(14), pp. 1149-1158. (doi:10.1136/heartjnl-2015-307558) (PMID:26006717)

Zannad, F., Greenberg, B., Cleland, J. G.F. , Gheorghiade, M., van Veldhuisen, D. J., Mehra, M. R., Anker, S. D., Byra, W. M., Fu, M. and Mills, R. M. (2015) Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial. European Journal of Heart Failure, 17(7), pp. 735-742. (doi:10.1002/ejhf.266) (PMID:25919061) (PMCID:PMC5029775)

Inglis, S. C., Conway, A., Cleland, J. G.F. and Clark, R. A. (2015) Is age a factor in the success or failure of remote monitoring in heart failure? Telemonitoring and structured telephone support in elderly heart failure patients. European Journal of Cardiovascular Nursing, 14(3), pp. 248-255. (doi:10.1177/1474515114530611) (PMID:24681423)

Kristensen, S. L., Jhund, P. S. , Køber, L., McKelvie, R. S., Zile, M. R., Anand, I. S., Komajda, M., Cleland, J. G.F. , Carson, P. E. and McMurray, J. J.V. (2015) Relative importance of history of heart failure hospitalization and N-terminal pro–B-type natriuretic peptide level as predictors of outcomes in patients with heart failure and preserved ejection fraction. JACC: Heart Failure, 3(6), pp. 478-486. (doi:10.1016/j.jchf.2015.01.014) (PMID:26046842)

Costanzo, P., Cleland, J. G.F. , Pellicori, P., Clark, A. L., Hepburn, D., Kilpatrick, E. S., Perrone-Filardi, P., Zhang, J. and Atkin, S. L. (2015) The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Annals of Internal Medicine, 162(9), pp. 610-618. (doi:10.7326/M14-1551) (PMID:25938991)

Davison, B. A. et al. (2015) Worsening heart failure following admission for acute heart failure: a pooled analysis of the PROTECT and RELAX-AHF studies. JACC: Heart Failure, 3(5), pp. 395-403. (doi:10.1016/j.jchf.2015.01.007) (PMID:25951761)

Filippatos, G. et al. (2015) International REgistry to assess medical practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry. European Journal of Heart Failure, 17(5), pp. 527-533. (doi:10.1002/ejhf.262) (PMID:25754836) (PMCID:PMC5024037)

Cleland, J. G.F. and Butcher, C. (2015) When is it appropriate to withdraw cardiac resynchronization therapy? Guesses and evidence. JACC: Heart Failure, 3(4), pp. 337-339. (doi:10.1016/j.jchf.2015.01.003) (PMID:25770401)

Pellicori, P., Zhang, J., Lukaschuk, E., Joseph, A.C., Bourantas, C.V., Loh, H., Bragadeesh, T., Clark, A.L. and Cleland, J.G.F. (2015) Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value. European Heart Journal, 36(12), pp. 733-742. (doi:10.1093/eurheartj/ehu405) (PMID:25336215)

Jankowska, E. A. et al. (2015) Bone marrow iron depletion is common in patients with coronary artery disease. International Journal of Cardiology, 182, pp. 517-522. (doi:10.1016/j.ijcard.2014.10.006) (PMID:25661858)

Dierckx, R., Cleland, J. G.F. , Parsons, S., Putzu, P., Pellicori, P., Dicken, B., Boyalla, V. and Clark, A. L. (2015) Prescribing patterns to optimize heart rate. JACC: Heart Failure, 3(3), pp. 224-230. (doi:10.1016/j.jchf.2014.11.003) (PMID:25650369)

Khand, A. U., Chew, P. G., Douglas, H., Jones, J., Jan, A. and Cleland, J.G.F. (2015) The effect of carvedilol on b-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation. Cardiology, 130(3), pp. 153-158. (doi:10.1159/000368746) (PMID:25660493)

Metra, M. et al. (2015) Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study. Journal of Cardiac Failure, 21(3), pp. 179-88. (doi:10.1016/j.cardfail.2014.12.012) (PMID:25573829)

Pellicori, P. and Cleland, J. G.F. (2015) Update on management of heart failure with preserved ejection fraction. Current Opinion in Cardiology, 30(2), pp. 173-178. (doi:10.1097/HCO.0000000000000152) (PMID:25603033)

Kristensen, S. L. et al. (2015) Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction. European Journal of Heart Failure, 17(2), pp. 169-176. (doi:10.1002/ejhf.211) (PMID:25756844)

Dickstein, K. et al. (2015) European cardiac resynchronization therapy survey II: rationale and design. Europace, 17(1), pp. 137-141. (doi:10.1093/europace/euu312) (PMID:25414481)

Dierckx, R., Pellicori, P., Cleland, J.G.F. and Clark, A.L. (2015) Telemonitoring in heart failure: Big Brother watching over you. Heart Failure Reviews, 20(1), pp. 107-116. (doi:10.1007/s10741-014-9449-4) (PMID:24972644)

Metra, M. et al. (2015) Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial. European Journal of Heart Failure, 17(1), pp. 109-118. (doi:10.1002/ejhf.207) (PMID:25431336)

Badar, A. A. et al. (2014) Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). European Heart Journal, 35(48), pp. 3426-3433. (doi:10.1093/eurheartj/ehu342)

Kotecha, D. et al. (2014) Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet, 384(9961), pp. 2235-2243. (doi:10.1016/S0140-6736(14)61373-8) (PMID:25193873)

Stut, W., Deighan, C., Armitage, W., Clark, M., Cleland, J. G. and Jaarsma, T. (2014) Design and usage of the HeartCycle education and coaching program for patients with heart failure. JMIR Research Protocols, 3(4), e72. (doi:10.2196/resprot.3411) (PMID:25499976) (PMCID:PMC4275507)

Cotter, G. et al. (2014) Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study. European Journal of Heart Failure, 16(12), pp. 1362-1371. (doi:10.1002/ejhf.186) (PMID:25371147)

Pellicori, P. and Cleland, J. G.F. (2014) Heart failure with preserved ejection fraction. Clinical Medicine, 14(S6), s22-s28. (doi:10.7861/clinmedicine.14-6-s22) (PMID:25468914)

Shoaib, A. et al. (2014) Breathlessness at rest is not the dominant presentation of patients admitted with heart failure. European Journal of Heart Failure, 16(12), pp. 1283-1291. (doi:10.1002/ejhf.153) (PMID:25452165)

Ahmad, T. et al. (2014) Charting a roadmap for heart failure biomarker studies. JACC: Heart Failure, 2(5), pp. 477-488. (doi:10.1016/j.jchf.2014.02.005) (PMID:24929535) (PMCID:PMC4194170)

Cleland, J. G.F. , Hutchinson, K., Pellicori, P. and Clark, A. (2014) Lipid-modifying treatments for heart failure: is their use justified? Heart Failure Clinics, 10(4), pp. 621-634. (doi:10.1016/j.hfc.2014.07.006) (PMID:25217437)

Parsons, S., Clark, A. L. and Cleland, J. G.F. (2014) The remarkable effect of ivabradine in two adolescents with dilated cardiomyopathy. Clinical Research in Cardiology, 103(10), pp. 847-849. (doi:10.1007/s00392-014-0731-1) (PMID:24920068)

Jankowska, E. A. et al. (2014) Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. European Heart Journal, 35(36), pp. 2468-2476. (doi:10.1093/eurheartj/ehu235) (PMID:24927731)

Dicken, B. and Cleland, J. G.F. (2014) Is the way to a man’s heart through his stomach? Intestinal blood flow, gut permeability, and heart failure. Journal of the American College of Cardiology, 64(11), pp. 1103-1105. (doi:10.1016/j.jacc.2014.06.1180)

Hutchinson, K., Pellicori, P., Dierckx, R., Cleland, J. G.F. and Clark, A. L. (2014) Remote telemonitoring for patients with heart failure: might monitoring pulmonary artery pressure become routine? Expert Review of Cardiovascular Therapy, 12(8), pp. 1025-1033. (doi:10.1586/14779072.2014.935340) (PMID:24984847)

Mabote, T., Wong, K. and Cleland, J. G.F. (2014) The utility of novel non-invasive technologies for remote hemodynamic monitoring in chronic heart failure. Expert Review of Cardiovascular Therapy, 12(8), pp. 923-928. (doi:10.1586/14779072.2014.935339) (PMID:25026973)

Stewart, R. A.H. et al. (2014) Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). JACC: Heart Failure, 2(4), pp. 335-343. (doi:10.1016/j.jchf.2014.02.009) (PMID:25023813) (PMCID:PMC4127151)

Cleland, J. G.F. , Pellicori, P. and Dierckx, R. (2014) Clinical trials in patients with heart failure and preserved left ventricular ejection fraction. Heart Failure Clinics, 10(3), pp. 511-523. (doi:10.1016/j.hfc.2014.04.011) (PMID:24975913)

Cullington, D., Goode, K. M., Zhang, J., Cleland, J. G.F. and Clark, A. L. (2014) Is heart rate important for patients with heart failure in atrial fibrillation? JACC: Heart Failure, 2(3), pp. 213-220. (doi:10.1016/j.jchf.2014.01.005) (PMID:24952686)

Goode, K. M., Nicholls, R., Pellicori, P., Clark, A. L. and Cleland, J. G.F. (2014) The in vitro stability of novel cardiovascular and sepsis biomarkers at ambient temperature. Clinical Chemistry and Laboratory Medicine, 52(6), pp. 911-918. (doi:10.1515/cclm-2013-0767) (PMID:24406281)

Ingle, L., Cleland, J.G. and Clark, A.L. (2014) The relation between repeated 6-minute walk test performance and outcome in patients with chronic heart failure. Annals of Physical and Rehabilitation Medicine, 57(4), pp. 244-253. (doi:10.1016/j.rehab.2014.03.004) (PMID:24835160)

Mentz, R. J. et al. (2014) International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial. European Journal of Heart Failure, 16(6), pp. 614-624. (doi:10.1002/ejhf.92) (PMID:24771609)

Rogers, J. K. et al. (2014) Effect of rosuvastatin on repeat heart failure hospitalizations: The CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC: Heart Failure, 2(3), pp. 289-297. (doi:10.1016/j.jchf.2013.12.007)

Valente, M.A.E. et al. (2014) Diuretic response in acute heart failure: clinical characteristics and prognostic significance. European Heart Journal, 35(19), pp. 1284-1293. (doi:10.1093/eurheartj/ehu065) (PMID:24585267)

Ingle, L., Rigby, A. S., Sloan, R., Carroll, S., Goode, K. M., Cleland, J. G. and Clark, A. L. (2014) Development of a composite model derived from cardiopulmonary exercise tests to predict mortality risk in patients with mild-to-moderate heart failure. Heart, 100(10), pp. 781-786. (doi:10.1136/heartjnl-2013-304614) (PMID:24567314)

Mentz, R. J. et al. (2014) Decongestion in acute heart failure. European Journal of Heart Failure, 16(5), pp. 471-482. (doi:10.1002/ejhf.74) (PMID:24599738) (PMCID:PMC4659502)

Cleland, J. G.F. and Parsons, S. (2014) Aspirin for heart failure: theory- or evidence-based? Circulation: Heart Failure, 7(2), pp. 237-238. (doi:10.1161/CIRCHEARTFAILURE.114.001155) (PMID:24643886)

Poolsawad, N., Moore, L., Kambhampati, C. and Cleland, J. G.F. (2014) Issues in the mining of heart failure datasets. International Journal of Automation and Computing, 11(2), pp. 162-179. (doi:10.1007/s11633-014-0778-5)

Perez-Moreno, A. C. et al. (2014) Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC: Heart Failure, 2(2), pp. 187-197. (doi:10.1016/j.jchf.2014.01.001)

Ingle, L., Cleland, J. G. and Clark, A. L. (2014) The long-term prognostic significance of 6-minute walk test distance in patients with chronic heart failure. BioMed Research International, 2014, 505969. (doi:10.1155/2014/505969) (PMID:24800236) (PMCID:PMC3985138)

Gheorghiade, M. et al. (2014) Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions. Heart Failure Reviews, 19(2), pp. 135-152. (doi:10.1007/s10741-012-9361-8) (PMID:23099992) (PMCID:PMC4161017)

Perez, A. C., Jhund, P. S. , Stott, D. J., Gullestad, L., Cleland, J. G.F. , van Veldhuisen, D. J., Wikstrand, J., Kjekshus, J. and McMurray, J. J.V. (2014) Thyroid-stimulating hormone and clinical outcomes. JACC: Heart Failure, 2(1), pp. 35-40. (doi:10.1016/j.jchf.2013.07.008)

Cleland, J.G. et al. (2014) Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function (PROTECT) study. Circulation: Heart Failure, 7(1), pp. 76-87. (doi:10.1161/CIRCHEARTFAILURE.113.000284) (PMID:24281134)

Givertz, M.M. et al. (2014) Renal function trajectories and clinical outcomes in acute heart failure. Circulation: Heart Failure, 7(1), pp. 59-67. (doi:10.1161/CIRCHEARTFAILURE.113.000556) (PMID:24281137)

Dobre, D. et al. (2014) Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties. European Journal of Heart Failure, 16(1), pp. 76-85. (doi:10.1093/eurjhf/hft129) (PMID:23928650)

Bouri, S., Whinnett, Z. I., Cole, G. D., Manisty, C. H., Cleland, J. G.F. and Francis, D. P. (2014) Definitions of outcome, response and effect in imaging research to avoid confusion. JACC: Cardiovascular Imaging, 7(1), pp. 104-106. (doi:10.1016/j.jcmg.2013.11.001) (PMID:24433715)

Pellicori, P., Kallvikbacka-Bennett, A., Zhang, J., Khaleva, O., Warden, J., Clark, A. L. and Cleland, J. G.F. (2014) Revisiting a classical clinical sign: Jugular venous ultrasound. International Journal of Cardiology, 170(3), pp. 364-370. (doi:10.1016/j.ijcard.2013.11.015) (PMID:24315339)

Lewinter, C., Bland, J. M., Crouch, S., Cleland, J. G.F. , Doherty, P., LeWinter, M. M., Køber, L., Hall, A. S. and Gale, C. P. (2014) Impact of aspirin and statins on long-term survival in patients hospitalized with acute myocardial infarction complicated by heart failure: an analysis of 1706 patients. European Journal of Heart Failure, 16(1), pp. 95-102. (doi:10.1002/ejhf.40) (PMID:24453098)

Pellicori, P., Kallvikbacka-Bennett, A., Khaleva, O., Carubelli, V., Costanzo, P., Castiello, T., Wong, K., Zhang, J., Cleland, J. G.F. and Clark, A. L. (2014) Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification? International Journal of Cardiovascular Imaging, 30(1), pp. 69-79. (doi:10.1007/s10554-013-0310-y) (PMID:24150723)

Jacobs, L. et al. (2014) Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common database. Journal of Biomedical Research, 28(5), pp. 349-359. (doi:10.7555/JBR.28.20140045) (PMID:25332706) (PMCID:PMC4197385)

Brignole, M. et al. (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace, 15(8), pp. 1070-1118. (doi:10.1093/europace/eut206)

Cleland, J. G. , Abraham, W. T., Linde, C., Gold, M. R., Young, J. B., Daubert, J. C., Sherfesee, L., Wells, G. A. and Tang, A. S.L. (2013) An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. European Heart Journal, 34(46), pp. 3547-3556. (doi:10.1093/eurheartj/eht290) (PMID:23900696) (PMCID:PMC3855551)

Ingle, L., Sloan, R., Carroll, S., Goode, K., Cleland, J. G. and Clark, A. L. (2012) Influence of body mass on risk prediction during cardiopulmonary exercise testing in patients with chronic heart failure. Experimental and Clinical Cardiology, 17(4), pp. 179-182. (PMID:23592931) (PMCID:PMC3627270)

Pepera, G. K., Sandercock, G. R., Sloan, R., Cleland, J. J.F. , Ingle, L. and Clark, A. L. (2012) Influence of step length on 6-minute walk test performance in patients with chronic heart failure. Physiotherapy, 98(4), pp. 325-329. (doi:10.1016/j.physio.2011.08.005) (PMID:23122439)

Rho, R. W., Patton, K. K., Poole, J. E., Cleland, J. G. , Shadman, R., Anand, I., Maggioni, A. P., Carson, P. E., Swedberg, K. and Levy, W. C. (2012) Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator. Circulation, 126(20), pp. 2402-2407. (doi:10.1161/CIRCULATIONAHA.111.069245) (PMID:23072904)

Buga, L. and Cleland, J. G.F. (2012) Increasing knowledge and changing views in cardiac resynchronization therapy. Heart Failure Reviews, 17(6), pp. 721-725. (doi:10.1007/s10741-011-9281-z) (PMID:21932145)

Cleland, J. G.F. and Ghio, S. (2012) The determinants of clinical outcome and clinical response to CRT are not the same. Heart Failure Reviews, 17(6), pp. 755-766. (doi:10.1007/s10741-011-9268-9) (PMID:22081054)

Pellicori, P., Sherwi, N., Khaleva, O., Wong, K. and Cleland, J. G.F. (2012) An atrial mass: the value of echocardiographic three-dimensional reconstruction. Journal of Cardiovascular Medicine, 13(11), pp. 769-770. (doi:10.2459/JCM.0b013e32834917ed) (PMID:21709575)

Cleland, J. G.F. and Clark, A. L. (2012) Heart failure—does it matter whether LVEF is reduced? Lancet, 380(9851), pp. 1363-1365. (doi:10.1016/S0140-6736(12)61349-X) (PMID:22932711)

Manzano, L., Escobar, C., Cleland, J. G.F. and Flather, M. (2012) Diagnosis of elderly patients with heart failure. European Journal of Heart Failure, 14(10), pp. 1097-1103. (doi:10.1093/eurjhf/hfs109) (PMID:22771845)

Daubert, J.-C. et al. (2012) 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm, 9(9), pp. 1524-1576. (doi:10.1016/j.hrthm.2012.07.025) (PMID:22939223)

Storrow, A. B. et al. (2012) Standardized reporting criteria for studies evaluating suspected acute heart failure syndromes in the emergency department. Journal of the American College of Cardiology, 60(9), pp. 822-832. (doi:10.1016/j.jacc.2012.03.072) (PMID:22917006)

Kohan, D. E., Cleland, J. G. , Rubin, L. J., Theodorescu, D. and Barton, M. (2012) Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve? Life Sciences, 91(13-14), pp. 528-539. (doi:10.1016/j.lfs.2012.07.034) (PMID:22967485)

Oxberry, S. G., Bland, J. M., Clark, A. L., Cleland, J. G.F. and Johnson, M. J. (2012) Minimally clinically important difference in chronic breathlessness: Every little helps. American Heart Journal, 164(2), pp. 229-235. (doi:10.1016/j.ahj.2012.05.003) (PMID:22877809)

Bourantas, C. V. et al. (2012) Renal artery stenosis: an innocent bystander or an independent predictor of worse outcome in patients with chronic heart failure? A magnetic resonance imaging study. European Journal of Heart Failure, 14(7), pp. 764-772. (doi:10.1093/eurjhf/hfs057) (PMID:22508558)

Cullington, D., Goode, K. M., Clark, A. L. and Cleland, J. G.F. (2012) Heart rate achieved or beta-blocker dose in patients with chronic heart failure: which is the better target? European Journal of Heart Failure, 14(7), pp. 737-747. (doi:10.1093/eurjhf/hfs060) (PMID:22622001)

Ingle, L., Hobkirk, J., Damy, T., Nabb, S., Clark, A. L. and Cleland, J. G.F. (2012) Experiences of air travel in patients with chronic heart failure. International Journal of Cardiology, 158(1), pp. 66-70. (doi:10.1016/j.ijcard.2010.12.101) (PMID:21256607) (PMCID:PMC3387374)

Cleland, J. G.F. , Freemantle, N., Erdmann, E., Gras, D., Kappenberger, L., Tavazzi, L. and Daubert, J.-C. (2012) Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. European Journal of Heart Failure, 14(6), pp. 628-634. (doi:10.1093/eurjhf/hfs055) (PMID:22552183)

Cleland, J. G.F. , Mumtaz, S. and Cecchini, L. (2012) Role of antithrombotic agents in heart failure. Current Cardiology Reports, 14(3), pp. 314-325. (doi:10.1007/s11886-012-0266-x) (PMID:22467260)

O'Connor, C. M. et al. (2012) The PROTECT in-hospital risk model: 7-day outcome in patients hospitalized with acute heart failure and renal dysfunction. European Journal of Heart Failure, 14(6), pp. 605-612. (doi:10.1093/eurjhf/hfs029) (PMID:22535795)

Ingle, L., Cleland, J. G. and Clark, A. L. (2012) Body mass index is related to the perception of exertional breathlessness in patients presenting with dyspnoea of unknown origin. International Journal of Cardiology, 157(2), pp. 300-303. (doi:10.1016/j.ijcard.2012.03.113) (PMID:22483253)

Cleland, J. G.F. , Taylor, J., Freemantle, N., Goode, K. M., Rigby, A. S. and Tendera, M. (2012) Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study. European Journal of Heart Failure, 14(5), pp. 487-494. (doi:10.1093/eurjhf/hfs049) (PMID:22505395)

Cleland, J. G.F. (2012) Does aspirin really reduce the risk of colon cancer? Lancet, 379(9826), p. 1586. (doi:10.1016/S0140-6736(12)60671-0) (PMID:22541575)

Bourantas, C. V. et al. (2012) Atherosclerotic disease of the abdominal aorta and its branches: prognostic implications in patients with heart failure. Heart Failure Reviews, 17(2), pp. 229-239. (doi:10.1007/s10741-011-9284-9) (PMID:22002211)

Broch, K. et al. (2012) Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology. European Journal of Heart Failure, 14(3), pp. 268-277. (doi:10.1093/eurjhf/hfs006) (PMID:22302661)

Cleland, J. G.F. , Carubelli, V., Castiello, T., Yassin, A., Pellicori, P. and Antony, R. (2012) Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart Failure Reviews, 17(2), pp. 133-149. (doi:10.1007/s10741-012-9306-2) (PMID:22426973)

Damy, T. et al. (2012) Prevalence of, associations with, and prognostic value of Tricuspid Annular Plane Systolic Excursion (TAPSE) among out-patients referred for the evaluation of heart failure. Journal of Cardiac Failure, 18(3), pp. 216-225. (doi:10.1016/j.cardfail.2011.12.003) (PMID:22385942)

Teerlink, J. R. et al. (2012) The safety of an adenosine A1-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: Findings from PROTECT. Drug Safety, 35(3), pp. 233-244. (doi:10.2165/11594680-000000000-00000) (PMID:22339573)

Ardehali, H. et al. (2012) Targeting myocardial substrate metabolism in heart failure: potential for new therapies. European Journal of Heart Failure, 14(2), pp. 120-129. (doi:10.1093/eurjhf/hfr173) (PMID:22253453) (PMCID:PMC3260022)

Cleland, J. G.F. (2012) Systematic reporting bias in meta-analyses of trials of aspirin for the primary prevention of cardiovascular disease. American Journal of Medicine, 125(2), e13. (doi:10.1016/j.amjmed.2011.08.027) (PMID:22269629)

Costanzo, P., Cleland, J.G. , Atkin, S. L., Vassallo, E. and Perrone-Filardi, P. (2012) Use of carotid intima-media thickness regression to guide therapy and management of cardiac risks. Current Treatment Options in Cardiovascular Medicine, 14(1), pp. 50-56. (doi:10.1007/s11936-011-0158-1) (PMID:22139639)

Rossignol, P., Cleland, J. G.F. , Bhandari, S., Tala, S., Gustafsson, F., Fay, R., Lamiral, Z., Dobre, D., Pitt, B. and Zannad, F. (2012) Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study. Circulation, 125(2), pp. 271-279. (doi:10.1161/CIRCULATIONAHA.111.028282) (PMID:22128223)

Bogale, N. et al. (2012) The European CRT Survey: 1 year (9-15 months) follow-up results. European Journal of Heart Failure, 14(1), pp. 61-73. (doi:10.1093/eurjhf/hfr158) (PMID:22179034)

Lopez-Andrès, N., Rossignol, P., Iraqi, W., Fay, R., Nuée, J., Ghio, S., Cleland, J. G.F. , Zannad, F. and Lacolley, P. (2012) Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. European Journal of Heart Failure, 14(1), pp. 74-81. (doi:10.1093/eurjhf/hfr151) (PMID:22089058)

Gullestad, L. et al. (2012) Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). European Heart Journal, 33(18), pp. 2290-2296. (doi:10.1093/eurheartj/ehs077) (PMID:22513778)

Ingle, L., Sloan, R., Carroll, S., Goode, K., Cleland, J. G. and Clark, A. L. (2012) Abnormalities of the ventilatory equivalent for carbon dioxide in patients with chronic heart failure. Pulmonary Medicine, 2012, 589164. (doi:10.1155/2012/589164) (PMID:22619715) (PMCID:PMC3350981)

Zannad, F. et al. (2012) Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements? European Heart Journal, 33(9), pp. 1049-1057. (doi:10.1093/eurheartj/ehr437) (PMID:22422830)

Cleland, J. G.F. , Coletta, A. P., Cullington, D., Castiello, T., de Boer, R. A. and Clark, A. L. (2011) Clinical trials update from the European Society of Cardiology Meeting 2011: ARISTOTLE, SMART-AV: QLV substudy, SHIFT: echocardiography and quality of life substudies, European CRT Survey, and Basic Science Update. European Journal of Heart Failure, 13(12), pp. 1376-1380. (doi:10.1093/eurjhf/hfr149) (PMID:22102626)

Damy, T. et al. (2011) Does the physical examination still have a role in patients with suspected heart failure? European Journal of Heart Failure, 13(12), pp. 1340-1348. (doi:10.1093/eurjhf/hfr128) (PMID:21990340)

Lewinter, C., Torp-Pedersen, C., Cleland, J. G.F. and Køber, L. (2011) Right and left bundle branch block as predictors of long-term mortality following myocardial infarction. European Journal of Heart Failure, 13(12), pp. 1349-1354. (doi:10.1093/eurjhf/hfr130) (PMID:22027083)

O'Connor, C. M. et al. (2011) Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the PROTECT pilot study. Circulation: Heart Failure, 4(6), pp. 724-732. (doi:10.1161/CIRCHEARTFAILURE.111.961581) (PMID:21900185)

Ariti, C. A., Cleland, J. G.F. , Pocock, S. J., Pfeffer, M. A., Swedberg, K., Granger, C. B., McMurray, J. J.V. , Michelson, E. L., Östergren, J. and Yusuf, S. (2011) Days alive and out of hospital and the patient journey in patients with heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. American Heart Journal, 162(5), pp. 900-906. (doi:10.1016/j.ahj.2011.08.003) (PMID:22093207)

Harinstein, M. E. et al. (2011) Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period. Heart, 97(19), pp. 1607-1618. (doi:10.1136/hrt.2011.222331) (PMID:21900586)

Cleland, J. G.F. , Coletta, A. P., Castiello, T. and Clark, A. L. (2011) Clinical trials update from the European Society of Cardiology Heart Failure meeting 2011: TEHAF, WHICH, CARVIVA, and atrial fibrillation in GISSI-HF and EMPHASIS-HF. European Journal of Heart Failure, 13(10), pp. 1147-1151. (doi:10.1093/eurjhf/hfr119) (PMID:21896537)

Anand, I. S. et al. (2011) Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Circulation: Heart Failure, 4(5), pp. 569-577. (doi:10.1161/CIRCHEARTFAILURE.111.962654) (PMID:21715583)

Costanzo, P., Cleland, J. G. , Vassallo, E. and Perrone-Filardi, P. (2011) Questioning the predictive role of carotid intima–media thickness. Future Cardiology, 7(5), pp. 651-656. (doi:10.2217/fca.11.44) (PMID:21929345)

Cleland, J. G.F. and Antony, R. (2011) It makes SENSE to take a safer road. European Heart Journal, 32(18), pp. 2225-2227. (doi:10.1093/eurheartj/ehr120) (PMID:21551157)

Inglis, S. C., Clark, R. A., McAlister, F. A., Stewart, S. and Cleland, J. G.F. (2011) Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. European Journal of Heart Failure, 13(9), pp. 1028-1040. (doi:10.1093/eurjhf/hfr039) (PMID:21733889)

Oxberry, S. G., Torgerson, D. J., Bland, J. M., Clark, A. L., Cleland, J. G.F. and Johnson, M. J. (2011) Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial. European Journal of Heart Failure, 13(9), pp. 1006-1012. (doi:10.1093/eurjhf/hfr068) (PMID:21712288)

Cleland, J. G.F. et al. (2011) The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet, 378(9792), pp. 676-683. (doi:10.1016/S0140-6736(11)61126-4) (PMID:21856481)

Cleland, J. G.F. , McDonagh, T. and Dargie, H. J. (2011) The authors' reply. Heart, 97(14), p. 1191. (doi:10.1136/heartjnl-2011-300372)

Cleland, J. G.F. and Freemantle, N. (2011) Revascularization for patients with heart failure. Inconsistencies between theory and practice. European Journal of Heart Failure, 13(7), pp. 694-697. (doi:10.1093/eurjhf/hfr075) (PMID:21712291)

Metra, M. et al. (2011) Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study. European Heart Journal, 32(12), pp. 1519-1534. (doi:10.1093/eurheartj/ehr042) (PMID:21388992)

Voors, A. A. et al. (2011) Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function). Journal of the American College of Cardiology, 57(19), pp. 1899-1907. (doi:10.1016/j.jacc.2010.11.057) (PMID:21545947)

Ingle, L., Sloan, R., Carroll, S., Goode, K., Cleland, J. G. and Clark, A. L. (2011) Prognostic significance of different measures of the ventilation-carbon dioxide relation in patients with suspected heart failure. European Journal of Heart Failure, 13(5), pp. 537-542. (doi:10.1093/eurjhf/hfq238) (PMID:21247919)

Villard, E. et al. (2011) A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. European Heart Journal, 32(9), pp. 1065-1076. (doi:10.1093/eurheartj/ehr105) (PMID:21459883) (PMCID:PMC3086901)

Cleland, J. G.F. , Coletta, A. P., Buga, L., Antony, R., Pellicori, P., Freemantle, N. and Clark, A. L. (2011) Clinical trials update from the American Heart Association Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT. European Journal of Heart Failure, 13(4), pp. 460-465. (doi:10.1093/eurjhf/hfr015) (PMID:21436363)

Inglis, S. C., Clark, R. A. and Cleland, J. G.F. (2011) Telemonitoring in patients with heart failure [2]. New England Journal of Medicine, 364(11), pp. 1078-1080. (doi:10.1056/NEJMc1100395) (PMID:21410377)

Shelton, R. J., Brown, B. D., Allinson, A., Johnson, T., Smales, C., Jolly, S. and Cleland, J. G.F. (2011) A comparison between monophasic and biphasic defibrillation for the cardioversion of persistent atrial fibrillation in patients with and without heart failure. International Journal of Cardiology, 147(3), pp. 405-408. (doi:10.1016/j.ijcard.2009.09.545) (PMID:19861229)

Cleland, J. G.F. , Calvert, M., Freemantle, N., Arrow, Y., Ball, S. G., Bonser, R. S., Chattopadhyay, S., Norell, M. S., Pennell, D. J. and Senior, R. (2011) The Heart Failure Revascularisation Trial (HEART). European Journal of Heart Failure, 13(2), pp. 227-233. (doi:10.1093/eurjhf/hfq230) (PMID:21156659)

Frankenstein, L., Goode, K., Ingle, L., Remppis, A., Schellberg, D., Nelles, M., Katus, H.A., Clark, A.L., Cleland, J.G.F. and Zugck, C. (2011) Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status – Do we need specificity for sex and beta-blockers? International Journal of Cardiology, 147(1), pp. 74-78. (doi:10.1016/j.ijcard.2009.08.005) (PMID:19765836)

Bourantas, C. V. et al. (2011) Relationship between right ventricular volumes measured by cardiac magnetic resonance imaging and prognosis in patients with chronic heart failure. European Journal of Heart Failure, 13(1), pp. 52-60. (doi:10.1093/eurjhf/hfq161) (PMID:20930000)

Bogale, N., Witte, K., Priori, S., Cleland, J. , Auricchio, A., Gadler, F., Gitt, A., Limbourg, T., Linde, C. and Dickstein, K. (2011) The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. European Journal of Heart Failure, 13(9), pp. 974-983. (doi:10.1093/eurjhf/hfr085) (PMID:21771823)

Bourantas, C. V. et al. (2011) Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: A cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance, 13(1), 53. (doi:10.1186/1532-429X-13-53) (PMID:21936915) (PMCID:PMC3190338)

Cleland, J. G.F. , Coletta, A. P., Freemantle, N. and Clark, A. L. (2011) Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II. European Journal of Heart Failure, 13(7), pp. 805-808. (doi:10.1093/eurjhf/hfr077) (PMID:21712293)

Cleland, J. G.F. , McDonagh, T., Rigby, A. S., Yassin, A., Whittaker, T. and Dargie, H. J. (2011) The national heart failure audit for England and Wales 2008-2009. Heart, 97(11), pp. 876-886. (doi:10.1136/hrt.2010.209171) (PMID:21173198)

Cullington, D., Esmail, S., Hurren, S., Cleland, J.G.F. , Clark, A. L. and Alamgir, M. F. (2011) Unmasking the truth. BMJ Case Reports, 2011, bcr0720103. (doi:10.1136/bcr.07.2010.3193)

Cullington, D., Goode, K. M., Cleland, J. G.F. and Clark, A. L. (2011) Limited role for ivabradine in the treatment of chronic heart failure. Heart, 97(23), pp. 1961-1966. (doi:10.1136/heartjnl-2011-300041) (PMID:21917660)

Futter, J. E., Cleland, J. G.F. and Clark, A. L. (2011) Body mass indices and outcome in patients with chronic heart failure. European Journal of Heart Failure, 13(2), pp. 207-213. (doi:10.1093/eurjhf/hfq218) (PMID:21138908)

Massie, B. M. et al. (2010) Rolofylline, an adenosine A1−receptor antagonist, in acute heart failure. New England Journal of Medicine, 363(15), pp. 1419-1428. (doi:10.1056/NEJMoa0912613) (PMID:20925544)

Cleland, J. et al. (2009) Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). Journal of the American College of Cardiology, 54(20), pp. 1850-1859. (doi:10.1016/j.jacc.2009.06.041)

Coletta, A. P., Cleland, J. G.F. , Cullington, D. and Clark, A. L. (2008) Clinical trials update from heart rhythm 2008 and heart failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452. European Journal of Heart Failure, 10(9), pp. 917-920. (doi:10.1016/j.ejheart.2008.07.006) (PMID:18678526)

Coletta, A. P., Cullington, D., Clark, A. L. and Cleland, J. G.F. (2008) Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF. European Journal of Heart Failure, 10(12), pp. 1264-1267. (doi:10.1016/j.ejheart.2008.10.002) (PMID:19008149)

Cleland, J. G.F. , Coletta, A. P., Yassin, A., Hado, H., Cullington, D., Abdellah, A. T. and Clark, A. L. (2008) Clinical trials update from the American College of Cardiology 2008: carisma, trends, meta-analysis of cox-2 studies, hat, on-target, hyvet, accomplish, momentum, protect, horizon-hf and reverse. European Journal of Heart Failure, 10(6), pp. 614-620. (doi:10.1016/j.ejheart.2008.05.003) (PMID:18502685)

Goode, K. M., Nabb, S., Cleland, J. G.F. and Clark, A. L. (2008) A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic. Journal of Cardiac Failure, 14(5), pp. 379-387. (doi:10.1016/j.cardfail.2008.01.014) (PMID:18514929)

Pang, P. S. et al. (2008) A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. European Heart Journal, 29(6), pp. 816-824. (doi:10.1093/eurheartj/ehn048) (PMID:18310669)

Cleland, J. G.F. , Coletta, A. P., Abdellah, A. T., Cullington, D., Clark, A. L. and Rigby, A. S. (2008) Clinical trials update from the American Heart Association 2007: CORONA, Rethin0, MASCOT, AF-CHF, HART, MASTER, POISE and stem cell therapy. European Journal of Heart Failure, 10(1), pp. 102-108. (doi:10.1016/j.ejheart.2007.12.004) (PMID:18179987)

Cleland, J. G.F. (2008) Classification of the level of evidence in international guidelines for acute and chronic heart failure. Acute Heart Failure, pp. 885-891. (doi:10.1007/978-1-84628-782-4_82)

Cleland, J. G.F. , Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L. and Tavazzi, L. (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352(15), pp. 1539-1549. (doi:10.1056/NEJMoa050496) (PMID:15753115)

Cleland, J.G.F. , Pennell, D.J., Ray, S.G., Coats, A.J., Macfarlane, P.W., Murray, G.D., Mule, J.D., Vered, Z. and Lahiri, A. (2003) Myocardial viability as a determinant of the ejection fraction response to Carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet, 362(9377), pp. 14-21. (doi:10.1016/S0140-6736(03)13801-9) (PMID:12853194)

Poole-Wilson, P. A. et al. (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet, 362(9377), pp. 7-13. (doi:10.1016/S0140-6736(03)13800-7) (PMID:12853193)

Cleland, J. G.F. et al. (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet, 360(9346), pp. 1631-1639. (doi:10.1016/S0140-6736(02)11601-1) (PMID:12457785)

Follath, F. et al. (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet, 360(9328), pp. 196-202. (doi:10.1016/S0140-6736(02)09455-2) (PMID:12133653)

Book Sections

Cleland, J. G.F. (2008) The epidemiology of heart failure. In: Beattie, J. and Goodlin, S. (eds.) Supportive Care in Heart Failure. Oxford University Press: Oxford, pp. 9-26. ISBN 9780198570288 (doi:10.1093/acprof:oso/9780198570288.003.0002)

Conference Proceedings

Poolsawad, N., Moore, L., Kambhampati, C. and Cleland, J.G.F. (2012) Handling Missing Values in Data Mining - A Case Study of Heart Failure Dataset. In: 9th International Conference on Fuzzy Systems and Knowledge Discovery (FSKD), Sichuan, China, 29-31 May 2012, pp. 2934-2938. ISBN 9781467300254 (doi:10.1109/FSKD.2012.6233860)

This list was generated on Fri Aug 18 10:41:20 2017 BST.